Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2015);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;12.019;Q1;348;187;657;6637;6981;279;10.47;35.49;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;8.793;Q1;241;32;98;14357;2101;98;20.4;448.66;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;8.547;Q1;210;33;80;3820;1453;79;16.46;115.76;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
4;4700152457;Nano Today;journal;17480132;5.956;Q1;155;64;195;5748;2091;126;9.11;89.81;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;5.367;Q1;225;92;261;7981;2732;212;10.1;86.75;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;5.054;Q1;331;174;485;24836;8355;436;15.72;142.74;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
7;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;4.225;Q1;211;119;320;22603;3643;319;12.09;189.94;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
8;12611;Drug Resistance Updates;journal;13687646, 15322084;3.961;Q1;119;22;45;3481;504;42;8.79;158.23;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
9;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;3.573;Q1;227;307;882;17897;5872;813;6.19;58.3;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
10;12455;Molecular Therapy;journal;15250024, 15250016;3.473;Q1;185;214;760;8370;4955;630;6.44;39.11;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
11;26371;Natural Product Reports;journal;02650568, 14604752;3.471;Q1;188;77;228;12044;2406;222;10.78;156.42;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
12;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.4;Q1;233;307;905;38487;5648;894;6.3;125.36;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
13;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.222;Q1;190;180;554;7688;3250;529;5.27;42.71;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;18148;Pain;journal;18726623, 03043959;3.107;Q1;269;339;1148;16019;5914;876;5.11;47.25;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
15;4400151524;Particle and Fibre Toxicology;journal;17438977;3.074;Q1;105;34;186;2019;1705;180;9.36;59.38;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
16;19907;Medicinal Research Reviews;journal;01986325, 10981128;3.064;Q1;134;37;112;7413;1104;111;9.57;200.35;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
17;23010;Journal of Controlled Release;journal;18734995, 01683659;2.738;Q1;282;546;1422;35549;12545;1336;7.89;65.11;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
18;21100207003;Theranostics;journal;18387640;2.586;Q1;115;109;297;6584;2783;277;9.3;60.4;Australia;Pacific Region;Ivyspring International Publisher;2012-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
19;20435;Neuropharmacology;journal;00283908, 18737064;2.547;Q1;176;371;1266;25215;7250;1244;5.41;67.96;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
20;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;2.544;Q1;195;167;682;4686;3784;621;5.27;28.06;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
21;5100155080;Neurotherapeutics;journal;19337213;2.507;Q1;122;75;217;7269;1232;203;5.03;96.92;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
22;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;2.483;Q1;89;12;52;1775;337;47;6.31;147.92;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
23;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.446;Q1;276;685;2444;37305;14625;2421;5.99;54.46;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
24;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2.444;Q1;143;824;1915;37886;8985;1899;4.36;45.98;United States;Northern America;Public Library of Science;2007-2021;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
25;20084;British Journal of Pharmacology;journal;14765381, 00071188;2.374;Q1;223;442;1419;34860;7454;1391;5.47;78.87;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
26;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.343;Q1;269;1112;3042;38978;14171;2841;4.46;35.05;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
27;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;2.308;Q1;71;54;217;3025;1150;201;5.47;56.02;United States;Northern America;Cell Press;2012-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
28;20063;Biochemical Pharmacology;journal;18732968, 00062952;2.286;Q1;206;274;1041;16823;5952;902;5.61;61.4;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
29;21100225611;Advanced healthcare materials;journal;21922640, 21922659;2.284;Q1;105;264;502;16710;3225;479;6.13;63.3;United Kingdom;Western Europe;John Wiley and Sons Ltd;2012-2021;"Biomaterials (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1)"
30;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.259;Q1;203;389;1740;10281;7723;1476;4.12;26.43;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
31;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.251;Q1;146;125;381;6950;1873;367;4.89;55.6;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
32;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;2.216;Q1;139;108;372;6393;1889;337;5.25;59.19;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
33;110112;Journal of Immunotherapy;journal;15249557, 15374513;2.192;Q1;97;42;185;1524;803;180;4.2;36.29;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1)"
34;21169;Pharmacological Research;journal;10436618, 10961186;2.143;Q1;147;205;371;15193;2206;364;6.51;74.11;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q1)
35;24749;Addiction Biology;journal;13556215, 13691600;2.126;Q1;83;91;298;4915;1309;296;4.41;54.01;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
36;5400152706;Nanotoxicology;journal;17435390, 17435404;2.105;Q1;94;119;251;5887;1936;247;7.6;49.47;United Kingdom;Western Europe;Informa Healthcare;2007-2021;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
37;21196;Drug Discovery Today;journal;18785832, 13596446;2.09;Q1;185;176;580;11162;3583;540;5.67;63.42;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
38;19700176055;F1000 Biology Reports;journal;1757594X, 17404118;2.088;Q1;31;0;26;0;102;26;6.5;0;United Kingdom;Western Europe;Faculty of 1000 Ltd;2010-2013;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous)  (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
39;19617;Antiviral Research;journal;01663542, 18729096;2.06;Q1;134;184;622;9704;2982;593;5.2;52.74;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q1)"
40;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.037;Q1;202;197;567;11141;2492;566;4.49;56.55;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
41;23916;Environmental Pollution;journal;02697491, 18736424;2.003;Q1;249;481;1383;24796;7272;1341;5.27;51.55;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
42;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.953;Q1;94;131;384;12752;1801;372;4.48;97.34;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
43;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.948;Q1;100;35;81;4484;459;77;4.56;128.11;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
44;21100466864;Journal for ImmunoTherapy of Cancer;journal;20511426;1.929;Q1;80;83;63;2067;316;60;5.02;24.9;United Kingdom;Western Europe;BMJ Publishing Group;2013-2021;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1)"
45;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.903;Q1;118;235;496;13154;2316;478;4.66;55.97;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
46;19700178100;Nanotechnology, Science and Applications;journal;11778903;1.888;Q1;30;6;14;413;127;14;7.17;68.83;New Zealand;Pacific Region;Dove Medical Press Limited;2010-2012, 2014-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
47;21100214102;Frontiers in Pharmacology;journal;16639812;1.886;Q1;104;303;628;22107;2849;592;4.47;72.96;Switzerland;Western Europe;Frontiers Media S.A.;2010-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
48;26380;Drug and Alcohol Dependence;journal;03768716;1.885;Q1;173;449;1141;21262;4629;1129;3.83;47.35;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
49;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.857;Q1;133;200;484;10208;3588;475;6.8;51.04;United States;Northern America;Elsevier Inc.;2005-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
50;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.847;Q1;233;214;838;11715;3694;836;4.19;54.74;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
51;19427;Advances in Pharmacology;journal;15578925, 10543589;1.837;Q1;78;33;120;4514;447;0;3.41;136.79;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
52;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.819;Q1;134;131;618;8569;2965;609;4.96;65.41;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
53;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.806;Q1;117;32;137;5226;781;122;5.66;163.31;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
54;21100232818;Emerging Microbes and Infections;journal;22221751;1.785;Q1;68;49;113;1838;428;105;4.18;37.51;United Kingdom;Western Europe;Nature Publishing Group;2012-2021;"Drug Discovery (Q1); Infectious Diseases (Q1); Medicine (miscellaneous) (Q1); Microbiology (Q1); Parasitology (Q1); Epidemiology (Q2); Immunology (Q2); Virology (Q2)"
55;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;1.777;Q1;66;6;23;963;124;23;5.46;160.5;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
56;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.775;Q1;121;128;439;8796;1832;412;3.94;68.72;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
57;20783;Expert Review of Vaccines;journal;14760584, 17448395;1.772;Q1;91;107;459;9145;1597;408;3.43;85.47;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1); Immunology (Q2)"
58;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.764;Q1;113;178;549;9834;2287;534;4.05;55.25;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
59;21782;Psychopharmacology;journal;00333158, 14322072;1.721;Q1;202;394;1231;22429;4690;1168;3.62;56.93;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
60;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.716;Q1;77;62;259;4238;1022;247;4.14;68.35;United States;Northern America;Springer New York;2006-2021;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2); Neuroscience (miscellaneous) (Q2)"
61;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;1.688;Q1;40;27;91;1288;394;91;4.25;47.7;Netherlands;Western Europe;Elsevier BV;2011-2021;"Infectious Diseases (Q1); Parasitology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
62;25218;Toxicological Sciences;journal;10960929, 10966080;1.681;Q1;193;268;821;12136;3653;788;4.26;45.28;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
63;24604;Archives of Toxicology;journal;14320738, 03405761;1.675;Q1;121;204;540;14082;2859;451;5.55;69.03;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
64;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.672;Q1;96;154;348;18335;1384;334;4;119.06;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
65;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.664;Q1;177;282;715;14057;3513;713;4.87;49.85;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
66;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.664;Q1;169;108;217;5585;1268;210;5.6;51.71;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
67;19600166320;Protein and Cell;journal;16748018, 1674800X;1.659;Q1;74;111;320;4793;1001;290;3.36;43.18;China;Asiatic Region;Higher Education Press;2010-2021;"Biochemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Cell Biology (Q2)"
68;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.618;Q1;70;37;148;1516;519;139;2.96;40.97;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Genetics (Q2); Molecular Biology (Q2)"
69;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.605;Q1;138;430;1227;20342;6342;1214;5;47.31;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
70;144771;Clinical Trials;journal;17407753, 17407745;1.604;Q1;67;96;282;2352;501;235;1.63;24.5;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
71;145164;Human Genomics;journal;14739542, 14797364;1.598;Q1;59;31;71;1471;249;68;3.64;47.45;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
72;29311;Current Cancer Drug Targets;journal;15680096, 18735576;1.569;Q1;96;74;236;6413;955;224;4.12;86.66;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1); Cancer Research (Q2)"
73;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;1.569;Q1;43;25;55;555;228;51;5.15;22.2;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q2)"
74;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.563;Q1;115;133;382;7828;1524;379;3.87;58.86;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
75;24763;Addictive Behaviors;journal;03064603;1.562;Q1;135;326;772;12925;2615;766;3.2;39.65;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
76;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.562;Q1;175;273;1009;14032;4673;1006;4.38;51.4;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
77;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.553;Q1;75;125;464;6311;1555;348;3.26;50.49;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Physiology (medical) (Q2)"
78;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;1.553;Q1;53;56;269;2457;917;265;3.56;43.88;United States;Northern America;Springer New York;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
79;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.511;Q1;153;271;791;11580;2940;654;3.88;42.73;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
80;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;1.504;Q1;36;6;16;705;70;0;4.91;117.5;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
81;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.476;Q1;159;283;921;12718;3004;883;3.11;44.94;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
82;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;1.463;Q1;50;57;154;2744;693;150;4.71;48.14;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Internal Medicine (Q1); Pharmacology (Q1)"
83;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.449;Q1;90;74;216;3122;908;216;4.25;42.19;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
84;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.437;Q1;168;322;759;17729;3648;750;4.54;55.06;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
85;4000148406;Clinical Toxicology;journal;15569519, 15563650;1.403;Q1;98;138;460;2875;1091;320;2.35;20.83;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
86;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.399;Q1;129;113;343;5057;932;327;2.37;44.75;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
87;84948;Expert Opinion on Drug Delivery;journal;17425247;1.397;Q1;116;134;390;12297;2116;384;5.47;91.77;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
88;14990;Current Neuropharmacology;journal;18756190, 1570159X;1.392;Q1;82;77;127;8032;531;118;4.05;104.31;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2)"
89;21790;Antiviral Therapy;journal;20402058, 13596535;1.388;Q1;89;107;425;3198;1169;409;2.75;29.89;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
90;22477;Investigational New Drugs;journal;01676997, 15730646;1.388;Q1;90;141;589;4514;2078;586;3.7;32.01;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
91;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.382;Q1;39;42;122;1216;408;108;3.91;28.95;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
92;23053;Journal of Natural Products;journal;01633864, 15206025;1.382;Q1;147;402;1040;14212;4615;1034;3.99;35.35;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
93;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.373;Q1;95;54;173;2893;523;170;2.47;53.57;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
94;21237;Drug Safety;journal;01145916, 11791942;1.365;Q1;131;104;320;5108;1091;281;3.58;49.12;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
95;19600166302;Current Molecular Pharmacology;journal;18744702;1.354;Q1;42;35;77;3169;231;67;2.03;90.54;United Arab Emirates;Middle East;Bentham Science Publishers;2008-2021;"Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
96;25219;Toxicology;journal;0300483X, 18793185;1.345;Q1;165;155;560;8634;2373;547;4.32;55.7;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
97;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.341;Q1;109;132;440;11218;1714;434;3.84;84.98;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
98;21100777378;Therapeutic Advances in Vaccines;journal;20510136;1.335;Q1;5;0;6;0;36;6;6;0;United Kingdom;Western Europe;;;"Drug Discovery (Q1); Pharmacology (medical) (Q1); Immunology (Q2); Immunology and Allergy (Q2); Oncology (Q2)"
99;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.333;Q1;73;216;671;5602;2288;659;3.41;25.94;United States;Northern America;American Chemical Society;2010-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
100;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;1.323;Q1;145;587;1434;28830;7663;1407;4.68;49.11;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Organic Chemistry (Q1)"
101;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.321;Q1;182;220;769;9767;2826;758;3.55;44.4;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
102;26767;Altex;journal;1868596X, 18688551;1.32;Q1;57;36;127;1912;462;103;3.65;53.11;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
103;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.313;Q1;120;208;521;8550;1657;489;2.99;41.11;United States;Northern America;Landes Bioscience;2002-2021;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2); Oncology (Q2)"
104;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.301;Q1;163;234;672;12527;2727;656;3.35;53.53;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
105;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.298;Q1;229;911;2282;36535;10456;2245;4.52;40.1;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
106;4000148019;AAPS Journal;journal;15507416;1.295;Q1;118;139;349;6747;1641;337;4.37;48.54;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q1)
107;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.292;Q1;96;83;251;3876;797;242;3.18;46.7;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
108;19700174891;Perspectives in Medicinal Chemistry;journal;11773910, 1177391X;1.285;Q1;16;3;5;193;30;5;6;64.33;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2011, 2014-2016;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
109;25240;Toxicology Letters;journal;03784274, 18793169;1.281;Q1;150;243;967;10931;3829;944;3.86;44.98;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
110;18073;NeuroToxicology;journal;18729711, 0161813X;1.274;Q1;122;120;469;6819;1763;447;3.23;56.83;Netherlands;Western Europe;Elsevier;1979-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
111;17700156714;Pharmaceuticals;journal;14248247;1.273;Q1;69;44;206;3690;833;203;5;83.86;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
112;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.266;Q1;114;280;889;8763;2852;877;3.25;31.3;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
113;19700175015;Infection and Drug Resistance;journal;11786973;1.263;Q1;44;39;82;2276;321;82;4.31;58.36;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Infectious Diseases (Q2)"
114;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;1.259;Q1;48;50;192;1995;576;181;2.5;39.9;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
115;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.254;-;144;77;267;3336;916;260;3.19;43.32;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
116;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.242;Q1;166;614;1877;67431;6154;1727;3.17;109.82;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
117;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.238;Q1;71;68;204;3278;520;166;2.78;48.21;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
118;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;1.236;Q1;68;96;300;9663;1201;298;3.72;100.66;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery (Q1)
119;24028;Reproductive Toxicology;journal;08906238, 18731708;1.229;Q1;117;160;419;8259;1586;398;3.32;51.62;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q1)
120;20664;Current Drug Targets;journal;18735592, 13894501;1.219;Q1;107;177;486;17651;1566;451;3.18;99.72;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
121;16088;Journal of Nanobiotechnology;journal;14773155;1.219;Q1;84;89;155;4161;872;154;4.83;46.75;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
122;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;1.211;Q1;46;27;70;2347;254;66;3.8;86.93;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)"
123;22378;Vascular Pharmacology;journal;18793649, 15371891;1.208;Q1;100;118;211;6233;677;197;2.63;52.82;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q1); Molecular Medicine (Q2); Physiology (Q2)"
124;25096;Food and Chemical Toxicology;journal;18736351, 02786915;1.202;Q1;183;306;1974;16838;7485;1883;3.98;55.03;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
125;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;1.195;Q1;31;15;63;858;274;63;4.44;57.2;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
126;21100225613;Human gene therapy methods;journal;19466536, 19466544;1.192;Q1;31;28;114;817;292;114;2.19;29.18;United States;Northern America;Mary Ann Liebert Inc.;2012-2019;"Applied Microbiology and Biotechnology (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
127;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.18;Q1;91;177;508;12702;1810;494;3.65;71.76;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
128;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.18;Q1;39;57;160;1388;177;149;1.2;24.35;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
129;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;1.167;Q1;144;258;765;11168;3372;753;4.37;43.29;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
130;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.164;Q1;76;15;42;2911;244;42;5.7;194.07;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
131;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.162;Q1;76;69;133;4165;383;128;3.06;60.36;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
132;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.155;Q1;213;309;822;13862;3324;811;3.88;44.86;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
133;18071;Neurotoxicity Research;journal;14763524, 10298428;1.154;Q1;78;67;217;4816;782;215;3.32;71.88;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
134;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;1.152;Q1;205;706;1976;38624;7707;1958;3.62;54.71;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q1); Pharmacology (Q1)"
135;4400151608;ChemMedChem;journal;18607187, 18607179;1.151;Q1;106;222;773;9007;2159;760;2.63;40.57;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
136;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.146;Q1;114;182;664;6280;2026;583;2.96;34.51;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
137;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;1.143;Q1;175;771;2214;40279;9122;2212;4.14;52.24;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
138;21165;PharmacoEconomics;journal;11707690, 11792027;1.143;Q1;104;104;294;5466;729;245;2.43;52.56;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
139;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;1.136;Q1;98;154;550;7590;1736;540;3.09;49.29;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
140;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.13;Q1;139;218;776;12664;2430;771;3;58.09;United States;Northern America;Elsevier Inc.;1973-2021;"Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2); Clinical Biochemistry (Q2); Pharmacology (Q2)"
141;22072;Current Gene Therapy;journal;18755631, 15665232;1.122;Q1;75;52;136;4261;423;126;2.89;81.94;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Medicine (Q2); Genetics (clinical) (Q3); Molecular Biology (Q3)"
142;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.122;Q2;189;754;1853;38814;5818;1847;3.13;51.48;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q2)
143;24626;Cell Biology and Toxicology;journal;15736822, 07422091;1.114;Q1;64;22;91;1062;307;91;3.32;48.27;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Cell Biology (Q3)"
144;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;1.113;Q2;56;30;84;1534;328;81;3.48;51.13;United Kingdom;Western Europe;SAGE Publications Ltd;2008-2021;"Neurology (Q2); Neurology (clinical) (Q2); Pharmacology (Q2)"
145;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;1.11;Q2;52;60;177;2823;514;172;3.1;47.05;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
146;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;1.104;Q1;103;89;202;5293;617;191;2.79;59.47;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q1); Developmental Neuroscience (Q2); Cellular and Molecular Neuroscience (Q3)"
147;25224;Toxicology in Vitro;journal;18793177, 08872333;1.096;Q2;112;297;621;14119;2302;609;3.66;47.54;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
148;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;1.095;Q1;79;141;401;5843;1316;400;2.97;41.44;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
149;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;1.092;Q1;73;49;149;1700;448;144;2.8;34.69;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1)"
150;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;1.081;Q1;77;114;314;8332;1338;313;4.58;73.09;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
151;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;1.08;Q1;79;126;397;4930;1011;394;2.47;39.13;United States;Northern America;SAGE Publications Inc.;1996-2017;"Analytical Chemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
152;25214;Toxicologic Pathology;journal;15331601, 01926233;1.08;Q2;112;105;335;4571;825;331;1.95;43.53;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q1); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
153;24652;Chemico-Biological Interactions;journal;00092797;1.069;Q2;128;328;593;15466;1985;579;3.14;47.15;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
154;20473;Life Sciences;journal;18790631, 00243205;1.066;Q1;174;372;1027;19993;3094;1017;3.04;53.74;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
155;25075;Ecotoxicology;journal;09639292, 15733017;1.059;Q2;97;206;568;11003;1534;563;2.54;53.41;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
156;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.053;Q2;140;270;644;9992;1927;573;2.83;37.01;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
157;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;1.052;Q1;133;510;1415;16381;4881;1404;3.54;32.12;Netherlands;Western Europe;Elsevier;1983-2022;"Analytical Chemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1); Clinical Biochemistry (Q2)"
158;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;1.051;Q2;25;8;32;471;130;31;4.3;58.88;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Medicine (miscellaneous) (Q1); Reviews and References (medical) (Q1); Pharmacology (Q2)"
159;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;1.051;Q2;51;50;125;4861;372;122;2.57;97.22;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
160;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.05;Q1;94;16;134;859;400;131;3.77;53.69;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Medicine (Q2); Genetics (clinical) (Q3); Molecular Biology (Q3)"
161;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;1.046;Q1;66;114;258;3542;596;217;2.22;31.07;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
162;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.04;Q2;72;91;256;3418;651;241;2.69;37.56;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Immunology (Q2); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2)"
163;22411;Inflammopharmacology;journal;09254692, 15685608;1.031;Q2;55;32;113;1955;364;105;2.74;61.09;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
164;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.03;Q1;171;759;2258;31651;7189;2247;3.15;41.7;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
165;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.024;Q2;78;114;308;2720;775;293;2.52;23.86;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Environmental Chemistry (Q2); Toxicology (Q2)"
166;19700175143;Pharmacognosy Reviews (discontinued);journal;09737847, 09762787;1.019;Q1;54;24;65;1200;257;65;3.73;50;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Plant Science (Q1); Pharmacology (Q2)"
167;21207;Drug Discovery Today: Technologies;journal;17406749;1.009;Q1;53;41;140;1545;421;125;2.69;37.68;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology (Q1); Drug Discovery (Q1); Molecular Medicine (Q2)"
168;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;1.008;Q2;91;161;424;7897;1457;421;3.3;49.05;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
169;17067;Phytomedicine;journal;09447113, 1618095X;1.007;Q1;127;162;613;5467;2236;600;3.39;33.75;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
170;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.997;Q2;92;119;375;5459;967;369;2.54;45.87;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
171;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.996;Q2;113;93;258;5535;722;256;2.66;59.52;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Medicine (miscellaneous) (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Physiology (Q2); Toxicology (Q2); Cell Biology (Q3)"
172;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.993;Q2;121;186;550;5879;1505;515;2.83;31.61;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
173;4700152848;PPAR Research;journal;16874757, 16874765;0.992;Q1;52;23;151;1800;380;144;2.94;78.26;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Drug Discovery (Q1); Pharmacology (medical) (Q2)"
174;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.987;Q2;104;157;438;7321;1106;416;2.57;46.63;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
175;19700175230;Drug Design, Development and Therapy;journal;11778881;0.982;Q1;71;527;424;23818;1494;422;3.44;45.2;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
176;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.98;Q1;104;85;302;4154;971;295;3.33;48.87;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
177;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;0.978;Q2;100;146;439;8832;1322;408;2.9;60.49;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Molecular Medicine (Q2); Pharmacology (Q2); Cancer Research (Q3)"
178;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.978;Q2;107;161;416;7288;959;374;2.1;45.27;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
179;20663;Current Drug Metabolism;journal;18755453, 13892002;0.977;Q2;111;72;301;9288;1010;275;3.08;129;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q2); Pharmacology (Q2)"
180;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;0.973;Q2;69;389;1253;16560;2508;975;1.93;42.57;United States;Northern America;Landes Bioscience;2012-2021;"Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
181;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.973;Q2;52;80;222;1733;642;183;2.15;21.66;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
182;19700188352;Toxins;journal;20726651;0.971;Q2;91;342;455;20394;1938;447;4.02;59.63;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
183;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;0.968;Q1;186;446;1269;19581;3981;1202;2.96;43.9;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
184;22432;International Immunopharmacology;journal;18781705, 15675769;0.966;Q2;119;490;998;20543;2983;983;2.86;41.92;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
185;18966;Mutagenesis;journal;02678357, 14643804;0.965;Q2;95;90;228;4509;603;226;2.54;50.1;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
186;21167;Pharmacogenomics;journal;14622416, 17448042;0.965;Q2;94;178;635;9993;1459;528;2.28;56.14;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3)"
187;22410;Inflammation Research;journal;1420908X, 10233830;0.952;Q2;94;103;381;4789;989;376;2.84;46.5;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
188;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.948;Q2;87;136;428;4858;1061;427;2.45;35.72;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
189;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.948;Q2;47;46;155;1979;433;151;2.83;43.02;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Medicine (miscellaneous) (Q1); Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3)"
190;26512;Tetrahedron;journal;14645416, 00404020;0.941;Q1;226;1084;3718;58434;10957;3704;2.9;53.91;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Drug Discovery (Q1); Biochemistry (Q2); Organic Chemistry (Q2)"
191;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.936;Q2;81;90;263;5070;766;263;3.04;56.33;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
192;19700194010;MedChemComm;journal;20402503, 20402511;0.936;Q1;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Royal Society of Chemistry;2010-2019;"Pharmaceutical Science (Q1); Biochemistry (Q2)"
193;24785;Alcohol;journal;07418329;0.934;Q2;83;88;240;5617;595;231;2.43;63.83;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
194;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;0.927;Q1;80;168;601;9678;2532;599;4.11;57.61;United States;Northern America;American Scientific Publishers;2007-2020;"Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Nanoscience and Nanotechnology (Q2)"
195;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.923;Q1;154;1079;3884;31690;10468;3884;2.74;29.37;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
196;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.907;Q2;83;251;735;17110;2166;706;3.12;68.17;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
197;22319;Toxicon;journal;18793150, 00410101;0.904;Q2;133;270;768;12473;2122;749;2.6;46.2;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
198;23155;Current Vascular Pharmacology;journal;15701611, 18756212;0.897;Q2;63;96;310;7129;719;268;2.2;74.26;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
199;20051;BioDrugs;journal;11738804, 1179190X;0.894;Q2;71;35;146;2111;477;141;3.36;60.31;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
200;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;0.894;Q2;90;164;459;11343;1063;404;2.21;69.16;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)"
201;110172;Progress in Drug Research;book series;0071786X;0.888;Q1;44;8;23;941;62;19;2.7;117.63;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q3)"
202;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.885;Q2;103;103;357;3465;919;323;2.56;33.64;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q2); Toxicology (Q2)"
203;21100335701;Vaccines;journal;2076393X;0.882;Q2;50;51;44;4651;81;42;1.84;91.2;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2013-2021;"Drug Discovery (Q2); Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
204;20049;Behavioural Pharmacology;journal;14735849, 09558810;0.881;Q2;83;83;241;5623;570;238;2.26;67.75;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
205;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.868;Q2;44;79;215;2994;555;215;2.76;37.9;South Korea;Asiatic Region;Korean Society of Applied Pharmacology;2008-2021;"Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
206;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.867;Q2;93;115;361;6077;844;346;2.31;52.84;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
207;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.865;Q2;88;148;382;12625;1178;379;3.06;85.3;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
208;130063;Pharmacological Reports;journal;17341140;0.864;Q2;87;183;501;8844;1350;499;2.52;48.33;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
209;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.859;Q2;49;126;321;6671;658;267;1.84;52.94;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2021;"Biochemistry (medical) (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2)"
210;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;0.856;Q2;183;275;1185;34914;4702;1120;3.72;126.96;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Pharmacology (Q2); Molecular Medicine (Q3)"
211;21100218055;"BMC pharmacology &amp; toxicology";journal;20506511;0.853;Q2;34;41;160;1456;387;154;2.53;35.51;United Kingdom;Western Europe;BioMed Central Ltd.;2012-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
212;21100455212;Biomedical Reports;journal;20499434, 20499442;0.852;Q1;29;21;4;576;16;4;4;27.43;Greece;Western Europe;Spandidos Publications;2014-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
213;16573;Phytotherapy Research;journal;10991573, 0951418X;0.85;Q2;140;247;832;10066;2544;828;3.23;40.75;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
214;16533;Phytochemical Analysis;journal;09580344, 10991565;0.847;Q2;76;52;250;1484;682;247;2.86;28.54;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Plant Science (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
215;19700174889;Drug Target Insights;journal;11773928;0.845;Q1;13;5;17;225;52;17;3.23;45;Italy;Western Europe;AboutScience Srl;2008-2009, 2011-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
216;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.844;Q2;52;82;258;1905;207;243;0.8;23.23;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
217;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.843;Q2;58;71;236;1781;275;127;1.22;25.08;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q2); Molecular Medicine (Q3)"
218;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.837;Q2;75;82;198;3273;585;193;2.9;39.91;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
219;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.833;Q2;78;36;121;1448;352;118;2.86;40.22;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
220;25109;Inhalation Toxicology;journal;08958378, 10917691;0.832;Q2;90;84;270;4386;715;258;2.25;52.21;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
221;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;0.825;Q2;76;187;568;12466;1437;447;2.19;66.66;United Kingdom;Western Europe;Future Science;2009-2021;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
222;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.821;Q2;115;96;388;5011;845;388;2.16;52.2;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q2)"
223;10300153301;Expert Review of Clinical Pharmacology;journal;17512433, 17512441;0.817;Q1;46;58;249;4113;576;215;2.41;70.91;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
224;4000150314;Chemical Biology and Drug Design;journal;17470277;0.814;-;82;226;529;8727;1382;519;2.9;38.62;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q2); Molecular Medicine (Q3)"
225;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.81;Q2;109;293;375;10385;987;372;2.66;35.44;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
226;20027;BMC Pharmacology;journal;14712210;0.805;Q2;44;0;8;0;32;8;0;0;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
227;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.805;Q1;69;65;237;2463;582;212;1.87;37.89;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
228;10900153302;Biomarker Insights;journal;11772719;0.8;Q2;35;68;44;5487;110;43;1.86;80.69;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2021;"Biochemistry (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
229;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.8;Q1;57;132;445;4070;1138;410;2.77;30.83;United Kingdom;Western Europe;John Wiley and Sons Ltd;2009-2021;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Spectroscopy (Q2)"
230;25093;Environmental Toxicology;journal;15227278, 15204081;0.799;Q2;81;137;298;6475;761;297;2.48;47.26;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
231;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.799;Q2;88;261;635;10540;1710;634;2.59;40.38;Netherlands;Western Europe;Elsevier;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
232;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.798;Q2;51;24;162;972;337;153;1.96;40.5;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2015;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
233;18077;Fitoterapia;journal;0367326X, 18736971;0.795;Q2;110;230;762;8534;2391;761;2.85;37.1;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
234;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.792;Q2;70;65;341;2475;845;337;2.11;38.08;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3)"
235;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.788;Q2;80;57;169;1544;387;162;2.19;27.09;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
236;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.783;Q2;96;123;410;4015;931;403;2.4;32.64;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
237;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;0.783;Q1;88;132;530;9536;1322;484;1.95;72.24;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmaceutical Science (Q1); Biotechnology (Q2)"
238;19300156901;Dose-Response;journal;15593258;0.781;Q2;41;45;126;2842;284;119;2.56;63.16;United States;Northern America;International Dose-Response Society;2008-2021;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
239;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.778;Q2;80;228;634;8373;1512;629;2.15;36.72;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
240;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.778;Q2;55;28;118;1118;186;106;1.2;39.93;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
241;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148, 22123334;0.778;Q2;25;15;71;1210;172;69;2.46;80.67;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2017;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Endocrinology, Diabetes and Metabolism (Q2); Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3)"
242;19700175819;Patient Preference and Adherence;journal;1177889X;0.777;Q1;54;183;389;6422;883;385;2.13;35.09;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2)"
243;144790;Marine Drugs;journal;16603397;0.775;Q2;128;380;843;23009;3358;842;3.91;60.55;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q2)
244;14805;Steroids;journal;0039128X, 18785867;0.772;Q2;107;219;553;9867;1580;542;2.83;45.05;United States;Northern America;Elsevier Inc.;1963-2021;"Clinical Biochemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Endocrinology (Q3); Molecular Biology (Q3)"
245;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.769;Q2;62;74;205;2484;491;202;2.52;33.57;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
246;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.768;Q2;34;9;61;521;127;50;1.44;57.89;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2016;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
247;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.763;Q2;39;15;121;693;324;117;1.98;46.2;Egypt;Africa/Middle East;Hindawi Limited;2010-2021;"Pharmacology (Q2); Toxicology (Q2)"
248;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.761;Q1;95;88;270;5790;857;264;3.06;65.8;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
249;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.76;Q2;42;28;82;1689;154;76;1.81;60.32;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
250;19700200821;Therapeutic Delivery;journal;20415990, 20416008;0.76;Q1;52;116;377;7967;897;331;2.12;68.68;United Kingdom;Western Europe;Future Science;2010-2021;Pharmaceutical Science (Q1)
251;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.758;Q2;90;97;357;4417;538;351;1.41;45.54;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
252;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.752;Q2;56;44;128;1556;264;122;2.08;35.36;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
253;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.751;Q2;64;101;372;3634;690;342;1.9;35.98;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
254;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;0.75;Q2;122;219;708;21937;2107;628;2.9;100.17;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
255;15840;Journal of Antibiotics;journal;00218820, 18811469;0.75;Q2;84;137;392;3383;840;378;2.15;24.69;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
256;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.749;Q1;38;17;82;903;222;80;2.17;53.12;United States;Northern America;Hindawi Publishing Corporation;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
257;24578;Mathematical Medicine and Biology;journal;14778599;0.749;Q2;46;21;58;787;108;57;1.19;37.48;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Environmental Science (miscellaneous) (Q1); Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
258;26514;Tetrahedron Letters;journal;00404039, 18733581;0.748;Q2;173;1575;4971;61745;12696;4971;2.55;39.2;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3)"
259;21100241624;International Journal of Genomics;journal;2314436X, 23144378;0.744;Q1;29;66;90;3214;198;88;2.2;48.7;Egypt;Africa/Middle East;Hindawi Limited;2013-2021;"Pharmaceutical Science (Q1); Biochemistry (Q3); Genetics (Q3); Molecular Biology (Q3)"
260;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.743;Q1;48;158;499;4893;896;485;1.75;30.97;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
261;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.734;Q2;112;264;518;10712;1308;480;2.47;40.58;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
262;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.733;Q1;61;52;149;1987;406;144;2.66;38.21;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
263;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.731;Q2;66;86;153;4028;379;148;2.42;46.84;United States;Northern America;Academic Press Inc.;1971-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
264;25898;Journal of Peptide Science;journal;10752617, 10991387;0.729;Q2;68;111;316;5136;624;312;2.01;46.27;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
265;19374;AAPS PharmSciTech;journal;15309932;0.72;Q1;101;118;472;4408;1113;470;2.05;37.36;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
266;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.719;Q1;81;62;140;3237;389;140;2.7;52.21;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
267;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.717;Q2;64;52;162;2133;335;155;1.8;41.02;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
268;21100238633;BioImpacts;journal;22285652, 22285660;0.716;Q1;37;30;89;1182;214;80;2.65;39.4;Iran;Middle East;Tabriz University of Medical Sciences;2011-2021;"Pharmaceutical Science (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
269;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.708;Q2;76;125;339;3742;711;334;2.21;29.94;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
270;6400153120;Chinese Medicine;journal;17498546;0.706;Q2;45;38;78;1753;172;75;2.06;46.13;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
271;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.706;Q1;59;205;220;9412;543;213;2.42;45.91;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
272;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0.701;Q1;46;54;145;2869;305;133;2.16;53.13;United States;Northern America;Springer Publishing Company;2011-2021;Pharmaceutical Science (Q1)
273;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.697;Q2;87;177;480;8660;862;453;1.76;48.93;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
274;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.696;Q1;124;165;548;7910;1457;541;2.57;47.94;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
275;19700188360;Pharmaceutics;journal;19994923;0.695;Q1;68;37;106;1795;312;105;3.17;48.51;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010-2021;Pharmaceutical Science (Q1)
276;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.692;Q2;96;126;373;3559;829;330;2.18;28.25;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
277;4700152278;Drugs in Context;journal;17404398, 17451981;0.681;Q2;26;20;23;761;43;21;1.65;38.05;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Pharmacology (Q2); Molecular Medicine (Q3)"
278;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.68;Q2;63;55;255;1847;480;250;1.93;33.58;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3)"
279;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.678;Q2;37;67;265;887;362;165;1.49;13.24;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
280;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.672;Q2;90;248;584;9227;1291;575;2.19;37.21;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
281;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.658;Q2;93;241;599;9845;1541;597;2.57;40.85;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3)"
282;20770;Drug Delivery;journal;10717544, 15210464;0.653;Q1;72;113;152;5241;370;152;2.31;46.38;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
283;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.651;Q2;62;89;279;2706;387;270;1.41;30.4;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
284;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.649;Q1;122;283;948;9434;1839;929;1.81;33.34;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
285;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.649;Q1;54;88;237;3505;449;203;1.94;39.83;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1)"
286;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.642;Q2;33;72;215;2722;367;215;1.76;37.81;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q2); Physiology (Q3)"
287;19700188217;Bioanalysis;journal;17576180, 17576199;0.641;Q1;62;278;949;10695;1936;750;2.03;38.47;United Kingdom;Western Europe;Future Science;2009-2021;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Medicine (miscellaneous) (Q2); Clinical Biochemistry (Q3)"
288;21744;Planta Medica;journal;14390221, 00320943;0.638;Q1;122;200;649;8197;1523;638;2.13;40.99;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
289;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.637;Q2;77;64;232;2798;485;232;2.39;43.72;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
290;20570;Chemotherapy;journal;00093157, 14219794;0.635;Q2;58;34;183;803;314;181;1.52;23.62;Switzerland;Western Europe;S. Karger AG;1960-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3)"
291;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.632;Q2;40;47;146;2052;315;146;2.21;43.66;United States;Northern America;Informa Healthcare;2004-2021;"Toxicology (Q2); Immunology (Q3)"
292;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.63;Q1;65;85;292;3538;695;292;2.31;41.62;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
293;16948;Chirality;journal;1520636X, 08990042;0.63;Q2;80;140;384;4961;772;379;2.07;35.44;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
294;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.626;Q2;40;61;135;3284;308;130;2.16;53.84;Netherlands;Western Europe;Wageningen Academic Publishers;2009-2021;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
295;21194;Pharmacology;journal;00317012, 14230313;0.624;Q2;60;85;253;2771;453;251;1.64;32.6;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
296;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;0.623;Q1;29;3;30;172;78;30;1.91;57.33;United States;Northern America;Springer Science + Business Media;2010-2021;"Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Physical and Theoretical Chemistry (Q2); Oncology (Q3)"
297;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.621;Q2;54;20;42;421;88;41;1.89;21.05;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
298;13671;Biologicals;journal;10958320, 10451056;0.62;Q2;60;73;202;2295;371;198;1.97;31.44;United States;Northern America;Academic Press Inc.;1990-2021;"Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3)"
299;21100258853;F1000Research;journal;20461402;0.62;Q1;72;372;480;16199;533;465;1.14;43.55;United Kingdom;Western Europe;;2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q3)"
300;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.613;Q3;99;378;1037;5606;1230;608;1.22;14.83;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
301;25171;Mycotoxin Research;journal;18671632, 01787888;0.613;Q3;40;25;93;936;209;92;2.24;37.44;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q2); Microbiology (Q3); Toxicology (Q3)"
302;25106;Human and Experimental Toxicology;journal;09603271;0.607;Q3;82;132;407;5653;755;395;1.77;42.83;United States;Northern America;SAGE Publications Inc.;1981-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
303;14822;Xenobiotica;journal;00498254, 13665928;0.607;Q3;82;120;361;3967;709;354;1.8;33.06;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Pharmacology (Q3); Toxicology (Q3)"
304;19900192900;Molecular Informatics;journal;18681751, 18681743;0.592;Q2;70;68;231;3230;448;222;1.73;47.5;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
305;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.584;Q1;63;155;423;3996;722;405;1.62;25.78;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
306;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.579;Q3;58;71;373;2307;609;365;1.5;32.49;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
307;20634;Journal of Texture Studies;journal;00224901, 17454603;0.577;Q1;57;48;140;2014;229;139;1.51;41.96;United States;Northern America;Wiley-Blackwell;1969-2021;"Pharmaceutical Science (Q1); Food Science (Q2)"
308;23039;Journal of Liposome Research;journal;08982104, 15322394;0.576;Q1;53;34;109;1332;246;109;1.89;39.18;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q1)
309;26370;Molecules;journal;14203049;0.57;Q2;171;1355;3358;70665;10022;3347;2.81;52.15;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Analytical Chemistry (Q2); Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
310;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.566;Q3;32;48;153;1504;245;153;1.7;31.33;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
311;22205;Saudi Pharmaceutical Journal;journal;13190164;0.563;Q2;57;97;180;3091;449;175;2.61;31.87;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
312;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.562;Q3;53;85;333;3098;523;251;1.45;36.45;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
313;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.562;Q3;46;85;264;3781;444;262;1.73;44.48;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
314;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.561;Q3;34;17;53;812;102;53;1.62;47.76;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
315;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;0.56;Q2;36;28;64;1745;123;58;1.48;62.32;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
316;23942;Biomedical Chromatography;journal;10990801, 02693879;0.559;Q2;68;249;704;6602;1262;692;1.77;26.51;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Pharmacology (Q3); Molecular Biology (Q4)"
317;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.558;Q1;91;158;471;5227;721;470;1.4;33.08;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
318;20026;BMC Clinical Pharmacology;journal;14726904;0.557;Q3;39;0;14;0;43;14;0;0;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
319;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.557;Q3;42;21;91;530;159;86;1.93;25.24;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
320;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.557;Q2;50;57;322;1739;624;322;2;30.51;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2)"
321;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.555;Q2;31;32;80;1139;122;79;1.81;35.59;United States;Northern America;Springer New York;2006-2021;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
322;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.551;Q3;76;265;966;7040;1455;965;1.32;26.57;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
323;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.55;Q3;34;29;99;1144;203;98;1.48;39.45;Slovakia;Eastern Europe;Slovak Toxicology Society SETOX;2008-2020;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
324;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.543;Q2;47;55;256;2136;515;230;1.99;38.84;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
325;15340;Developments in Biologicals;journal;14246074, 16622960;0.538;Q3;38;0;42;0;49;41;1.82;0;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Biomaterials (Q3); Immunology (Q3); Pharmacology (Q3)"
326;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.533;Q3;93;138;415;5373;1178;392;3.13;38.93;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Toxicology (Q3)"
327;21100241601;Toxicology Research;journal;2045452X, 20454538;0.532;Q3;37;162;121;9765;375;117;2.42;60.28;United Kingdom;Western Europe;Oxford University Press;2012-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
328;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.531;Q3;25;17;66;635;120;60;1.71;37.35;New Zealand;Pacific Region;Dove Medical Press Limited;2009-2021;"Health Policy (Q2); Pharmacology (Q3)"
329;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.53;Q1;48;130;237;3480;308;213;1.11;26.77;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
330;21100197929;Toxicological Research;journal;19768257, 22342753;0.528;Q3;35;41;151;1390;229;151;1.68;33.9;South Korea;Asiatic Region;Koreal Association of Medical Journal Editors;2008-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
331;19700201201;EPMA Journal;journal;18785077, 18785085;0.526;Q2;39;25;42;1876;183;41;4.45;75.04;United Kingdom;Western Europe;BioMed Central Ltd.;2010-2021;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Health Policy (Q2)"
332;21100212330;Drug Discoveries and Therapeutics;journal;1881784X, 18817831;0.525;Q1;27;57;58;0;87;57;1.44;0;Japan;Asiatic Region;"International Advancement Center for Medicine &amp; Health Research Co., Ltd. (IACMHR Co., Ltd.)";1997, 2010-2018, 2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
333;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.522;Q3;53;67;293;2592;481;284;1.86;38.69;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
334;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.522;Q2;38;27;50;388;82;48;0.83;14.37;United States;Northern America;Old City Publishing;1996, 2002-2020;"Drug Discovery (Q2); Cancer Research (Q3); Pharmacology (Q3)"
335;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.522;Q3;62;155;322;6052;520;322;1.37;39.05;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
336;16067;Reading Teacher;journal;00340561;0.521;Q3;53;89;240;1981;250;211;0.76;22.26;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (medical) (Q2); Pharmacology (Q3)"
337;5800173386;Current Drug Safety;journal;15748863;0.518;Q3;37;47;137;1521;206;130;1.41;32.36;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
338;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.516;Q2;66;90;239;3286;436;232;1.82;36.51;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Chemistry (miscellaneous) (Q2); Colloid and Surface Chemistry (Q2); Dermatology (Q2); Drug Discovery (Q2); Pharmaceutical Science (Q2); Aging (Q3)"
339;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.515;Q3;40;27;97;906;118;86;0.84;33.56;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Hematology (Q3); Pharmacology (Q3)"
340;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.515;Q2;81;88;259;3935;527;259;1.87;44.72;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Bioengineering (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Colloid and Surface Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
341;130025;Current Drug Delivery;journal;15672018;0.513;Q2;65;82;218;4298;411;209;1.55;52.41;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q2)
342;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.513;Q2;72;240;623;9910;1096;623;1.8;41.29;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
343;21100239265;PharmaNutrition;journal;22134344;0.513;Q3;23;25;47;1425;93;43;1.98;57;Netherlands;Western Europe;Elsevier BV;2013-2021;"Food Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
344;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.512;Q3;64;50;113;1491;155;91;1.46;29.82;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
345;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.512;Q3;52;70;195;1923;275;175;1.27;27.47;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
346;5800173383;Current Clinical Pharmacology;journal;15748847, 22123938;0.511;Q1;0;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers;2006-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
347;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.511;Q3;42;46;87;1574;184;87;2.03;34.22;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Public Health, Environmental and Occupational Health (Q2); Safety Research (Q2); Toxicology (Q3)"
348;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0.509;Q1;42;93;210;3315;371;209;1.86;35.65;Iran;Middle East;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
349;21100825823;Pharmacology Research and Perspectives;journal;20521707;0.508;Q1;32;104;70;4419;99;70;1.41;42.49;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neurology (Q3)"
350;59665;Chinese Journal of Natural Medicines;journal;16723651;0.506;Q2;40;121;331;4561;609;331;1.94;37.69;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
351;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.503;Q1;35;152;522;2509;430;282;0.8;16.51;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Anesthesiology and Pain Medicine (Q2); Pharmacology (medical) (Q2)"
352;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.501;Q3;67;121;375;2036;423;335;1.06;16.83;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
353;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.498;Q3;46;62;196;2731;324;194;1.74;44.05;United States;Northern America;Informa Healthcare;1977-2021;"Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
354;20578;Journal of Food and Drug Analysis;journal;10219498;0.497;Q3;63;100;303;3541;478;297;2.18;35.41;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q2); Pharmacology (Q3)"
355;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.489;Q2;62;119;362;4431;560;360;1.66;37.24;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
356;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.487;Q3;47;30;95;1373;145;95;1.56;45.77;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
357;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.486;Q3;24;23;88;868;143;79;1.62;37.74;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
358;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.482;Q1;69;175;652;3951;1013;540;1.42;22.58;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
359;29053;Molecular Diversity;journal;1573501X, 13811991;0.481;Q2;58;72;214;3596;459;214;2.22;49.94;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Drug Discovery (Q2); Information Systems (Q2); Medicine (miscellaneous) (Q2); Catalysis (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Molecular Biology (Q4)"
360;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;0.481;Q2;18;33;105;833;56;102;0.69;25.24;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Pharmaceutical Science (Q2); Statistics and Probability (Q3)"
361;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.48;Q3;52;25;135;976;170;134;1.27;39.04;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Developmental Biology (Q4)"
362;21264;Drugs in R and D;journal;11796901, 11745886;0.479;Q3;47;35;97;1269;169;96;1.57;36.26;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q3)
363;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.479;Q2;39;73;189;1758;227;165;1.01;24.08;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q3)"
364;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.479;Q1;61;112;370;4338;615;352;1.59;38.73;China;Asiatic Region;Zhejiang University Press;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
365;19700174941;Pharmacognosy Research (discontinued);journal;09748490;0.479;Q2;37;72;147;2274;235;144;1.4;31.58;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2019, 2021;"Drug Discovery (Q2); Pharmacology (Q3)"
366;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.477;Q3;48;9;97;936;115;75;0.41;104;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q3); Toxicology (Q3)"
367;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.477;Q3;62;65;206;2871;286;195;1.19;44.17;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
368;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.475;Q2;38;37;109;710;160;89;1.17;19.19;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;Pharmaceutical Science (Q2)
369;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876, 2221285X;0.474;Q2;48;50;143;2029;282;141;2.4;40.58;China;Asiatic Region;Shenyang Pharmaceutical University;2009-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
370;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.473;Q2;60;40;120;953;240;120;1.6;23.83;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
371;130047;Current Drug Discovery Technologies;journal;15701638;0.473;Q2;44;26;93;1516;162;86;1.73;58.31;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q2)
372;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.472;Q2;65;114;149;4479;527;143;2.85;39.29;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
373;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.469;Q2;50;55;152;2528;285;149;1.99;45.96;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Molecular Medicine (Q3)"
374;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X, 22124071;0.463;Q2;0;0;0;0;0;0;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2020;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Infectious Diseases (Q3); Pharmacology (medical) (Q3)"
375;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.459;Q2;48;73;314;2200;423;309;1.47;30.14;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Biochemistry (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
376;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.458;Q2;33;115;166;3540;295;166;1.44;30.78;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology (Q2); Drug Discovery (Q2); Pharmacology (Q3)"
377;23412;Journal of AOAC International;journal;10603271;0.456;Q3;90;239;676;5727;891;664;1.05;23.96;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Environmental Chemistry (Q3); Pharmacology (Q3)"
378;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.453;Q2;85;169;659;5854;880;658;1.21;34.64;United States;Northern America;Wiley-Blackwell;1918-2021;"Drug Discovery (Q2); Biochemistry (Q3); Catalysis (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
379;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.451;Q2;44;181;392;6688;596;385;1.49;36.95;Iran;Middle East;Mashhad University of Medical Sciences;2007-2021;"Drug Discovery (Q2); Biochemistry (Q3); Biophysics (Q3); Clinical Biochemistry (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
380;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.451;Q1;50;355;1564;13104;2476;1564;1.58;36.91;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3)"
381;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.447;Q1;36;31;93;1400;144;81;1.23;45.16;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q3)"
382;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0.443;Q2;38;47;196;1565;329;196;1.66;33.3;China;Asiatic Region;Xi'an Jiaotong University;2011-2021;"Pharmacy (Q1); Drug Discovery (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Electrochemistry (Q3); Spectroscopy (Q3)"
383;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.443;Q2;33;60;118;2368;205;118;1.73;39.47;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
384;21100469670;Antibiotics;journal;20796382;0.44;Q2;47;38;78;2381;117;75;1.55;62.66;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010, 2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q3); Infectious Diseases (Q3); Microbiology (Q3); Microbiology (medical) (Q3); Pharmacology (medical) (Q3)"
385;21717;Die Pharmazie;journal;00317144;0.44;Q2;66;126;513;3978;738;512;1.37;31.57;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
386;130031;Journal of Toxicologic Pathology;journal;09149198;0.439;Q3;30;33;125;802;125;123;0.93;24.3;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
387;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.437;Q3;95;118;399;9356;1250;384;3.11;79.29;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
388;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.435;Q3;53;63;206;2045;307;202;1.73;32.46;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
389;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.433;Q3;27;0;27;0;29;24;1.44;0;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Molecular Medicine (Q3)"
390;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.428;Q3;50;84;242;3130;310;242;1.17;37.26;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
391;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.425;Q2;28;34;102;982;126;99;1.13;28.88;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
392;16836;BMC Chemical Biology;journal;14726769;0.423;Q3;20;0;5;0;14;5;0;0;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q3); Molecular Medicine (Q3)"
393;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.421;Q3;69;131;403;3103;529;387;1.32;23.69;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
394;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;0.421;Q3;29;19;72;1526;115;69;1.46;80.32;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Drug Discovery (Q3); Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3)"
395;19900192163;Results in Pharma Sciences;journal;22112863;0.417;Q2;16;1;22;34;38;22;0.78;34;Netherlands;Western Europe;Elsevier BV;2011-2016;Pharmaceutical Science (Q2)
396;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.412;Q3;95;151;600;4331;872;600;1.37;28.68;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
397;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.411;Q3;37;41;181;1461;246;173;1.18;35.63;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
398;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.411;Q3;74;107;223;3566;306;220;1.41;33.33;United States;Northern America;Wiley-Blackwell;1986-2021;"Biomedical Engineering (Q2); Process Chemistry and Technology (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
399;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;0.41;Q2;50;104;360;4341;503;350;1.39;41.74;Brazil;Latin America;Springer Nature Switzerland AG;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
400;19700175105;Open Drug Delivery Journal;journal;18741266;0.405;Q2;5;0;1;0;2;1;2;0;Netherlands;Western Europe;;;Pharmaceutical Science (Q2)
401;17500155003;Records of Natural Products;journal;13076167;0.404;Q3;33;111;175;2819;222;174;1.07;25.4;Turkey;Middle East;ACG Publications;2009-2022;"Plant Science (Q2); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
402;27210;In Vivo;journal;17917549, 0258851X;0.401;Q3;64;107;443;3766;470;443;1.01;35.2;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
403;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.4;Q3;32;50;103;1760;152;94;1.36;35.2;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
404;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.392;Q3;28;7;64;683;84;60;1.03;97.57;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2015;"Cardiology and Cardiovascular Medicine (Q3); Drug Discovery (Q3); Pharmacology (medical) (Q3)"
405;19200156706;Pharmacognosy Magazine (discontinued);journal;09731296, 09764062;0.385;Q2;42;114;244;3247;298;239;1.04;28.48;India;Asiatic Region;Wolters Kluwer Medknow Publications;2008-2018, 2020-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
406;21100241608;Journal of Nanomedicine and Nanotechnology (discontinued);journal;21577439;0.383;Q2;24;0;109;0;160;82;1.97;0;United States;Northern America;OMICS Publishing Group;2010-2014;"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
407;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;0.382;Q2;26;64;139;1304;146;127;1.18;20.38;United States;Northern America;Wiley-Blackwell;2012-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q3)"
408;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.38;Q3;30;56;209;3666;162;209;0.69;65.46;United States;Northern America;Current Medicine Group;2007-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
409;144879;Toxicology International;journal;09716580;0.38;Q3;28;80;158;1937;196;153;0.97;24.21;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
410;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.378;Q2;61;120;304;2939;364;301;1.13;24.49;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
411;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.377;Q2;23;22;52;646;56;50;1.11;29.36;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3)"
412;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.375;Q3;21;9;16;363;19;16;1;40.33;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
413;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.374;Q2;16;11;53;224;45;39;0.89;20.36;United States;Northern America;IPEC-Americas;2010-2021;"Food Science (Q2); Pharmaceutical Science (Q2)"
414;21100318814;Pharmaceutical patent analyst;journal;20468954, 20468962;0.37;Q2;17;32;133;0;90;84;0.67;0;United Kingdom;Western Europe;Future Science;2012-2018, 2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
415;25864;Heterocycles;journal;03855414;0.368;Q3;66;244;765;9053;915;765;1.16;37.1;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
416;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.368;Q2;42;152;518;2760;622;518;1.15;18.16;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
417;21100426011;Nano LIFE;journal;17939844;0.366;Q2;1;0;1;0;4;1;4;0;Singapore;Asiatic Region;;;"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
418;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.363;Q3;62;159;517;3072;517;429;0.9;19.32;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
419;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.361;Q3;39;54;111;1538;159;111;1.47;28.48;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
420;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.359;Q2;45;145;432;4390;478;430;0.95;30.28;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
421;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0.358;Q2;42;260;342;5165;428;302;1.09;19.87;India;Asiatic Region;Wolters Kluwer Medknow Publications;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Bioengineering (Q3)"
422;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.357;Q3;20;132;338;860;165;132;0.71;6.52;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
423;21100219314;Applied and Translational Genomics;journal;22120661;0.355;Q2;21;40;54;1127;39;40;0.74;28.18;Netherlands;Western Europe;Elsevier BV;2012-2016;"Pharmaceutical Science (Q2); Biotechnology (Q3); Molecular Biology (Q4)"
424;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0.355;Q2;24;42;106;1200;127;97;1.18;28.57;Netherlands;Western Europe;Kowsar Publishing Company;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
425;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.355;Q2;46;51;208;1279;306;207;1.22;25.08;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
426;19700180522;Molecular and Cellular Toxicology;journal;20928467, 1738642X;0.354;Q2;23;50;150;1855;180;150;1.39;37.1;Germany;Western Europe;Springer Verlag;2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
427;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.353;Q3;63;104;364;2840;361;342;0.92;27.31;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
428;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.351;Q2;12;6;37;243;30;35;0.48;40.5;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
429;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.348;Q3;66;95;273;4448;331;253;1.08;46.82;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3)"
430;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.348;Q3;32;53;134;2523;178;125;1.76;47.6;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Animal Science and Zoology (Q3); Infectious Diseases (Q3); Toxicology (Q3); Parasitology (Q4)"
431;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.345;Q3;41;35;115;6113;132;16;1.09;174.66;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q3); Organic Chemistry (Q3)"
432;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;0.345;Q2;21;54;176;1592;118;157;0.65;29.48;United States;Northern America;Elsevier USA;2012-2021;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3)"
433;19700174961;BioProcess International;trade journal;15426319;0.344;Q3;23;148;428;1128;276;416;0.67;7.62;United States;Northern America;PJB Publications Ltd.;2009-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3)"
434;21192;Drug Development Research;journal;02724391, 10982299;0.342;Q3;62;51;203;2863;229;199;1.05;56.14;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
435;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.342;Q3;51;203;500;6085;435;499;0.75;29.98;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
436;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.34;Q3;38;52;147;1873;154;146;1;36.02;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q4)"
437;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.34;Q2;21;30;88;939;72;75;0.47;31.3;United Kingdom;Western Europe;BioMed Central Ltd.;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3)"
438;21100853513;Pharmaceutical Nanotechnology;journal;22117385, 22117393;0.338;Q2;13;5;5;534;6;5;1.2;106.8;Netherlands;Western Europe;Bentham Science Publishers B.V.;2014-2021;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3)"
439;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.337;Q3;29;0;49;0;36;44;0.5;0;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
440;20700195026;Acta Pharmaceutica Sinica B;journal;22113843, 22113835;0.334;Q2;65;73;14;3765;22;4;0.44;51.58;Netherlands;Western Europe;Elsevier BV;2012, 2014-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
441;19700174904;Asian Journal of Pharmaceutical and Clinical Research (discontinued);journal;09742441, 24553891;0.333;Q2;41;452;1223;12155;912;1222;0.6;26.89;India;Asiatic Region;Asian Journal of Pharmaceutical and Clinical Research;2009-2018, 2020-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
442;21100853576;Bulletin of Faculty of Pharmacy, Cairo University;journal;11100931;0.332;Q2;1;0;1;0;2;1;2;0;Egypt;Africa/Middle East;;;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
443;17700156705;Modern Trends in Pharmacopsychiatry;journal;16622685, 16624505;0.332;Q3;0;0;0;0;0;0;0;0;Switzerland;Western Europe;S. Karger AG;2009-2010, 2013, 2015, 2017;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Psychiatry and Mental Health (Q3)"
444;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.332;Q2;42;335;627;6903;590;627;0.84;20.61;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q2)
445;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;0.33;Q2;31;64;145;2108;171;144;1.38;32.94;Netherlands;Western Europe;Springer Netherlands;2012-2021;"Pharmaceutical Science (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
446;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.329;Q3;36;74;125;3010;111;122;0.78;40.68;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
447;35190;Revista Espanola de Quimioterapia;journal;02143429;0.327;Q3;26;78;160;1293;137;121;0.86;16.58;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
448;4500151530;Personalized Medicine;journal;17410541;0.325;Q3;33;65;271;2851;249;229;0.95;43.86;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
449;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.324;Q3;32;72;210;1764;268;207;1.28;24.5;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
450;130038;Letters in Drug Design and Discovery;journal;15701808;0.324;Q2;35;102;395;3479;397;391;1.06;34.11;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
451;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.324;Q3;50;539;1343;13358;1463;1323;1.02;24.78;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
452;19700175244;Current Radiopharmaceuticals;journal;18744710, 18744729;0.323;Q3;26;22;91;753;105;86;1.11;34.23;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2021;"Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
453;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.323;Q3;15;4;4;322;9;4;3;80.5;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010, 2012-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Molecular Medicine (Q4)"
454;19600162009;Advances in Molecular Toxicology;book series;18720854, 22122044;0.322;Q3;15;8;22;1420;33;0;0.79;177.5;Netherlands;Western Europe;Elsevier;2006, 2008-2018, 2020;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q4)"
455;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.322;Q3;31;46;117;1537;152;106;1.27;33.41;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
456;19700177128;Journal of Young Pharmacists (discontinued);journal;09751505, 09751483;0.321;Q2;30;71;131;1544;137;117;0.75;21.75;India;Asiatic Region;EManuscript Services;2010-2018, 2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
457;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.32;Q2;26;4;26;182;25;24;1.08;45.5;United States;Northern America;Lumitext Publishing;2009-2017, 2020-2021;"Pharmaceutical Science (Q2); Molecular Biology (Q4)"
458;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.316;Q3;46;90;343;4155;411;335;1.16;46.17;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q3)
459;144963;Drug Discovery Today: Disease Models;journal;17406757;0.31;Q3;28;22;93;1027;55;82;0.62;46.68;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q3); Molecular Medicine (Q4)"
460;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.31;Q2;18;3;15;116;23;15;1.64;38.67;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2020;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
461;19700170617;EXCLI Journal;journal;16112156;0.302;Q3;43;121;285;5643;377;245;1.48;46.64;Germany;Western Europe;Leibniz Research Centre for Working Environment and Human Factors;2009-2021;"Animal Science and Zoology (Q3); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
462;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;0.301;Q2;28;18;72;713;69;69;0.88;39.61;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019, 2021;"Pharmaceutical Science (Q2); Biochemistry (medical) (Q3); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
463;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.301;Q2;40;59;177;187;107;147;0.55;3.17;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
464;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.3;Q3;29;52;138;1406;129;114;0.79;27.04;Netherlands;Western Europe;Wolters Kluwer Medknow Publications;2010-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
465;18800156720;Dissolution Technologies;journal;1521298X;0.296;Q2;34;32;95;517;57;70;0.33;16.16;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
466;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.296;Q2;33;33;76;1650;127;74;1.83;50;Spain;Western Europe;Elsevier Espana;2005-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
467;4700152608;African Journal of Traditional, Complementary and Alternative Medicines (discontinued);journal;25050044, 01896016;0.295;Q3;48;127;426;4580;382;422;0.85;36.06;Nigeria;Africa;African Ethnomedicines Network;2006-2017;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
468;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences (discontinued);journal;09751491;0.292;Q2;49;1027;3740;30303;2307;3733;0.56;29.51;India;Asiatic Region;IJPPS;2009-2017, 2020-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
469;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.291;Q2;57;55;177;2106;189;176;1;38.29;United States;Northern America;Informa Healthcare;2013-2021;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3)"
470;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.291;-;31;83;200;1966;195;176;1;23.69;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q3)
471;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.29;Q2;51;233;669;6939;527;666;0.77;29.78;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Clinical Biochemistry (Q3); Biochemistry (Q4)"
472;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.288;Q4;61;60;204;1328;154;147;0.68;22.13;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Medical Laboratory Technology (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q4)"
473;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.288;Q3;10;13;43;908;15;1;0.42;69.85;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery (Q3); Organic Chemistry (Q4)"
474;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.287;Q4;48;33;120;952;111;110;0.88;28.85;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Biochemistry (Q4); Toxicology (Q4)"
475;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.284;Q3;53;51;203;1213;151;183;0.75;23.78;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
476;21100244805;Journal of Vaccines and Vaccination (discontinued);journal;21577560;0.284;Q3;12;0;145;0;61;123;0.44;0;United States;Northern America;OMICS Publishing Group;2010-2014;"Drug Discovery (Q3); Immunology (Q4); Immunology and Allergy (Q4); Virology (Q4)"
477;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.284;Q2;46;120;365;2681;181;323;0.47;22.34;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3); Public Health, Environmental and Occupational Health (Q3)"
478;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996, 15969827;0.282;Q2;39;308;575;7007;436;574;0.7;22.75;Nigeria;Africa;Pharmacotherapy Group;2009-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q3)"
479;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0.28;Q4;7;25;83;292;17;74;0.17;11.68;India;Asiatic Region;Punjab Academy of Forensic Medicine and Toxicology;2011-2020;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
480;21100367469;Toxicology Reports;journal;22147500;0.28;Q4;46;170;124;7621;121;123;0.98;44.83;Ireland;Western Europe;Elsevier Scientific Publishers Ireland;2014-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q4)"
481;4700152612;Current Nanoscience;journal;15734137;0.278;Q2;47;105;397;4739;454;389;1.09;45.13;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3); Nanoscience and Nanotechnology (Q3)"
482;21496;Revista de Chimie (discontinued);journal;00347752;0.277;-;31;403;853;9902;798;853;0.97;24.57;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
483;145693;Canadian Pharmacists Journal;journal;17151635;0.276;Q2;24;61;263;827;95;127;0.46;13.56;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
484;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;0.276;Q3;39;118;207;5051;174;207;0.76;42.81;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology (Q3)
485;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.274;Q2;27;49;144;1991;106;131;0.77;40.63;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
486;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.273;Q3;26;152;232;3800;196;230;0.87;25;Bangladesh;Asiatic Region;Bangladesh Pharmacological Society;2009-2021;Pharmacology (Q3)
487;21810;Farmacia;journal;00148237;0.273;Q2;27;150;336;3557;386;335;1.24;23.71;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
488;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.271;Q3;29;146;326;5415;189;317;0.49;37.09;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
489;19600156803;Journal of Medicinal Plant Research;journal;19960875;0.266;Q2;63;0;1;0;3;1;0;0;Nigeria;Africa;Academic Journals;2009-2012;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
490;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.264;Q2;21;8;35;717;42;0;1.59;89.63;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
491;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.263;Q3;10;13;33;732;13;33;0.39;56.31;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Virology (Q4)"
492;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.261;Q2;17;24;84;891;63;72;0.59;37.13;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q3); Neuroscience (miscellaneous) (Q4)"
493;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.259;Q3;14;26;74;794;48;69;0.78;30.54;United Kingdom;Western Europe;Inderscience Enterprises Ltd;2008-2021;"Computer Science Applications (Q3); Drug Discovery (Q3)"
494;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0.257;Q2;41;324;1040;9765;724;1037;0.61;30.14;India;Asiatic Region;MediPoeia;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
495;130089;Toxin Reviews;journal;15569543, 15569551;0.254;Q4;46;35;45;1566;41;43;0.82;44.74;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q4)
496;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.252;Q3;34;172;468;3269;223;468;0.42;19.01;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q3); Pharmacology (Q3)"
497;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.252;Q3;19;24;63;793;41;52;0.49;33.04;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
498;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.251;Q2;23;123;255;2930;139;245;0.48;23.82;United States;Northern America;Elsevier Inc.;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacy (Q2)"
499;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.25;Q2;52;115;256;4963;185;248;0.75;43.16;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
500;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.249;Q3;22;13;70;466;38;70;0.6;35.85;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q3)
501;19700174931;Asian Journal of Pharmaceutics (discontinued);journal;1998409X, 09738398;0.247;Q2;23;48;101;1392;77;100;0.68;29;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
502;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.246;Q2;25;19;47;668;36;47;0.57;35.16;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmaceutical Science (Q2); Pharmacology (nursing) (Q2); Sports Science (Q4)"
503;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.245;Q2;43;97;290;3014;202;279;0.61;31.07;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
504;17700156303;Neuromethods;book series;19406045, 08932336;0.245;Q2;21;265;403;12839;126;341;0.3;48.45;United States;Northern America;Humana Press;2009-2022;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Psychiatry and Mental Health (Q3); Neuroscience (miscellaneous) (Q4)"
505;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.243;Q4;28;18;43;698;36;43;0.74;38.78;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
506;19700175096;Pharmacognosy Journal;journal;09753575;0.242;Q3;25;62;244;1833;129;234;0.48;29.56;India;Asiatic Region;EManuscript Technologies;2009-2021;"Drug Discovery (Q3); Pharmacology (Q3)"
507;21100366771;Journal of Applied Research on Medicinal and Aromatic Plants;journal;22147861;0.24;Q3;24;30;20;1254;16;19;0.8;41.8;Germany;Western Europe;Elsevier GmbH;2014-2021;"Drug Discovery (Q3); Plant Science (Q3)"
508;21100470510;Drug Research;journal;21949379, 21949387;0.238;Q3;65;93;451;2452;308;443;0.68;26.37;Germany;Western Europe;Thieme;1972, 2013-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
509;5800173401;Current Bioactive Compounds;journal;15734072;0.237;Q2;27;38;102;1427;65;91;0.64;37.55;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
510;19700174978;American Journal of Pharmacy Benefits;journal;21642494, 19454481;0.236;Q2;15;55;161;1091;50;136;0.19;19.84;United States;Northern America;Managed Care and Healthcare Communications;2010-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Business and International Management (Q3); Decision Sciences (miscellaneous) (Q4)"
511;19700175060;International Journal of PharmTech Research (discontinued);journal;09744304;0.236;Q3;48;366;746;10887;419;746;0.46;29.75;India;Asiatic Region;Sphinx Knowledge House;2009-2016;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
512;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.236;Q2;24;80;201;1686;81;200;0.43;21.08;India;Asiatic Region;Rasayan Journal;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4)"
513;19500156813;Procedia in Vaccinology;journal;1877282X;0.235;Q3;15;0;21;0;16;21;0;0;Netherlands;Western Europe;Elsevier;2009-2012;"Drug Discovery (Q3); Infectious Diseases (Q3); Pharmaceutical Science (Q3); Immunology (Q4)"
514;19900193894;Open Pharmacoeconomics and Health Economics Journal;journal;18768245;0.233;Q2;3;0;6;0;4;6;0.5;0;Netherlands;Western Europe;;;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
515;13718;Pharmaceutical Engineering;journal;02738139;0.23;Q3;16;61;179;579;48;156;0.21;9.49;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
516;19700181240;Global Journal of Pharmacology (discontinued);journal;19920075;0.229;Q2;18;0;93;0;83;93;0.75;0;Pakistan;Asiatic Region;International Digital Organization for Scientific Information;2010-2014;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
517;19700174900;International Journal of Green Pharmacy (discontinued);journal;19984103, 09738258;0.228;Q3;26;57;162;1812;81;161;0.46;31.79;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
518;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.224;Q3;25;41;128;1380;94;125;0.96;33.66;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q3); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4)"
519;19700175858;Journal of Pharmacognosy and Phytotherapy (discontinued);journal;21412502;0.224;Q3;22;22;58;632;36;58;0.67;28.73;United States;Northern America;Academic Journals Inc.;2010-2017;Drug Discovery (Q3)
520;21100226424;Toxicology and Environmental Health Sciences;journal;20059752, 22337784;0.224;Q4;17;37;102;1594;85;102;0.88;43.08;South Korea;Asiatic Region;Korean Society of Environmental Risk Assessment and Health Science;2009-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
521;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.223;Q3;10;5;13;470;11;13;0.64;94;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010-2016, 2018;"Pharmacology (Q3); Biochemistry (Q4); Biophysics (Q4); Cell Biology (Q4)"
522;5400152620;American Journal of Pharmacology and Toxicology (discontinued);journal;15574970, 15574962;0.222;Q3;21;9;70;427;47;69;0.62;47.44;United States;Northern America;Science Publications;2007-2016;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
523;19446;American Pharmaceutical Review;journal;10998012;0.22;Q3;24;66;218;782;92;203;0.34;11.85;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
524;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0.22;Q3;10;20;40;509;20;40;0.33;25.45;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2012, 2014-2021;Pharmaceutical Science (Q3)
525;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.218;Q3;48;106;346;3258;220;345;0.54;30.74;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
526;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.217;Q3;16;33;105;974;53;94;0.61;29.52;United Kingdom;Western Europe;Oxford University Press;2010-2021;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
527;22881;Yaoxue Xuebao;journal;05134870;0.216;Q3;34;258;794;6292;483;794;0.57;24.39;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
528;21758;Prescrire International;journal;11677422;0.214;Q3;13;210;600;802;112;558;0.21;3.82;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
529;19700175099;Topics in Medicinal Chemistry;book series;1862247X, 18622461;0.214;Q3;12;21;43;3177;25;39;0.41;151.29;Germany;Western Europe;Springer Verlag;2009-2012, 2014-2021;"Drug Discovery (Q3); Molecular Medicine (Q4)"
530;21100285419;Expert Opinion on Orphan Drugs;journal;21678707;0.213;Q3;22;124;230;10230;118;227;0.51;82.5;United Kingdom;Western Europe;Taylor and Francis Ltd.;2013-2021;"Health Policy (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
531;19700174893;Dhaka University Journal of Pharmaceutical Sciences (discontinued);journal;18161839, 18161820;0.209;Q3;13;32;88;651;25;87;0.2;20.34;Bangladesh;Asiatic Region;University of Dhaka;2007-2018, 2020;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
532;19700201333;International Journal of Drug Delivery (discontinued);journal;09750215;0.206;Q3;15;9;106;207;53;106;0.51;23;United States;Northern America;Advanced Research Journals;2011-2015;Pharmaceutical Science (Q3)
533;19700201609;Open Natural Products Journal;journal;18748481;0.206;Q3;3;0;7;0;6;7;1.25;0;Netherlands;Western Europe;;;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q3)"
534;21100293201;International Journal of Research in Ayurveda and Pharmacy (discontinued);journal;22774343, 22293566;0.204;Q3;13;8;515;268;111;515;0.21;33.5;India;Asiatic Region;Moksha Publishing House;2012-2016;"Drug Discovery (Q3); Pharmaceutical Science (Q3)"
535;19700188319;International Journal of Pharmaceutical Sciences Review and Research (discontinued);journal;0976044X;0.2;Q3;33;601;1484;16892;539;1484;0.37;28.11;India;Asiatic Region;Global Research Online;2010-2016, 2020-2021;Pharmaceutical Science (Q3)
536;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.199;Q3;6;9;25;159;13;25;0.52;17.67;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2011, 2013-2021;"Drug Discovery (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3)"
537;21100202909;Drug Invention Today (discontinued);journal;09757619;0.198;Q3;20;2;148;51;119;147;1.53;25.5;India;Asiatic Region;Association of Pharmaceutical Innovators;2012-2021;Drug Discovery (Q3)
538;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.196;Q3;22;42;176;2295;88;170;0.46;54.64;Chile;Latin America;MS-Editions;2008-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q4)"
539;15600154705;EnvironmentAsia;journal;19061714;0.196;Q4;19;30;81;881;36;81;0.29;29.37;Thailand;Asiatic Region;Thai Society of Higher Eduation Institutes on Environment;2009-2021;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
540;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.194;Q3;24;58;296;657;89;201;0.32;11.33;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
541;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.194;Q3;29;35;101;1024;50;101;0.37;29.26;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
542;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0.194;Q3;0;0;0;0;0;0;0;0;Turkey;Middle East;Marmara University;2010-2019;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
543;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.194;Q3;16;34;114;1055;53;114;0.22;31.03;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
544;19700188355;International Journal of Phytomedicine (discontinued);journal;09750185;0.193;Q3;20;33;204;1079;83;204;0.28;32.7;United States;Northern America;Advanced Research Journals;2010-2016;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q3)"
545;19700175758;International Journal of Drug Development and Research (discontinued);journal;09759344;0.191;Q3;24;21;480;539;173;479;0.15;25.67;India;Asiatic Region;International Journal of Drug Development and Research;2010-2015;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
546;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.19;Q3;14;37;160;873;56;152;0.25;23.59;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Pharmacology (Q3); Drug Discovery (Q4); Plant Science (Q4)"
547;19700200724;Der Pharmacia Lettre (discontinued);journal;09755071;0.189;Q3;28;541;807;13661;405;807;0.49;25.25;India;Asiatic Region;Scholars Research Library;2011-2016;Pharmaceutical Science (Q3)
548;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;0.189;Q3;20;8;28;202;15;28;0.62;25.25;India;Asiatic Region;International Journal of Applied Pharmaceutics;2011-2021;Pharmaceutical Science (Q3)
549;11900154394;Oriental Journal of Chemistry (discontinued);journal;0970020X, 22315039;0.189;Q4;27;355;782;9530;386;781;0.54;26.85;India;Asiatic Region;Bhopal, S.A. Iqbal;1989, 2008-2018, 2021;"Chemistry (miscellaneous) (Q3); Biochemistry (Q4); Drug Discovery (Q4); Environmental Chemistry (Q4)"
550;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.188;Q3;4;68;164;1397;9;152;0.07;20.54;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
551;58808;Pharmaceutical Care and Research;journal;16712838;0.188;Q3;8;149;476;1329;37;475;0.07;8.92;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
552;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.188;Q3;9;30;107;459;11;85;0.12;15.3;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
553;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences (discontinued);journal;09758585;0.188;Q3;31;1611;2462;35122;648;2462;0.26;21.8;India;Asiatic Region;RJPBCS;2010-2017, 2020-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
554;19700171709;Arhiv za Farmaciju;journal;00041963;0.187;Q3;4;26;106;804;6;105;0.03;30.92;Serbia;Eastern Europe;Farmaceutsko Drustvo Srbije;1954-1955, 2009-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
555;19700200860;International Journal of Current Pharmaceutical Review and Research (discontinued);journal;0976822X;0.187;Q3;14;43;37;1384;15;37;0.33;32.19;India;Asiatic Region;Publishers, In-IJCPR;2010-2017;Pharmaceutical Science (Q3)
556;21100853564;AAPS Advances in the Pharmaceutical Sciences Series;book series;22107371, 2210738X;0.186;Q3;13;83;149;5030;49;145;0.33;60.6;Germany;Western Europe;Springer Verlag;2011, 2014-2021;Pharmaceutical Science (Q3)
557;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.186;Q3;10;8;39;684;19;39;0.76;85.5;New Zealand;Pacific Region;Libertas Academica Ltd.;2010-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q4)"
558;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;0.184;Q3;9;19;64;599;28;63;0.42;31.53;Iran;Middle East;Wolters Kluwer Medknow Publications;2012-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4)"
559;5800173394;Current Drug Therapy;journal;15748855;0.183;Q3;17;26;80;901;42;74;0.52;34.65;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
560;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.183;Q3;22;43;174;1138;54;173;0.23;26.47;India;Asiatic Region;Association of Pharmaceutical Teachers of India;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
561;23171;Korean Journal of Pharmacognosy;journal;02533073;0.183;Q3;17;51;101;1396;38;101;0.38;27.37;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
562;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.183;Q3;19;41;76;1308;40;74;0.59;31.9;Iran;Middle East;Tabriz University of Medical Sciences;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
563;9800153137;Trastornos Adictivos;journal;15750973;0.183;Q4;9;0;19;0;9;16;0;0;Spain;Western Europe;Ediciones Doyma, S.L.;2007-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
564;21100788810;Chemotherapy Research and Practice;journal;20902107;0.182;Q3;5;1;3;113;5;3;1.67;113;United States;Northern America;;;"Oncology (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
565;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0.182;Q3;13;108;266;2745;109;261;0.39;25.42;China;Asiatic Region;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-2021;Pharmaceutical Science (Q3)
566;15500154707;International Journal of Biological Chemistry (discontinued);journal;21522561, 1819155X;0.178;Q4;16;29;31;1206;17;31;0.27;41.59;Pakistan;Asiatic Region;Asian Network for Scientific Information;2009-2016;"Biochemistry (Q4); Pharmacology (Q4)"
567;19200156925;Cancer Therapy;journal;15439143, 15439135;0.176;Q4;8;0;15;0;6;15;0.31;0;United States;Northern America;Gene Therapy Press;2009-2014;"Cancer Research (Q4); Oncology (Q4); Pharmacology (Q4)"
568;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.176;Q4;19;8;47;88;14;45;0.39;11;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Pharmacy (Q2); Drug Guides (Q3); Pharmacology (Q4)"
569;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.174;Q4;19;25;95;1706;39;79;0.43;68.24;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2018, 2020;"Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
570;22338;Hospital Pharmacy;journal;19451253, 00185787;0.174;Q4;24;153;427;2276;148;382;0.45;14.88;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
571;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.173;Q4;24;22;63;1032;34;60;0.58;46.91;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q4); Pharmacology (Q4)"
572;21100228007;Archives of Razi Institute;journal;20089872, 03653439;0.173;Q4;10;34;76;897;20;76;0.31;26.38;Iran;Middle East;Razi Vaccine and Serum Research Institute;2012-2021;"Immunology and Microbiology (miscellaneous)  (Q4); Toxicology (Q4); Veterinary (miscellaneous) (Q4)"
573;23489;Chemical Speciation and Bioavailability;journal;09542299;0.173;Q4;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q4); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
574;130170;Phytotherapie;journal;17652847, 16248597;0.173;Q4;18;71;227;1479;44;157;0.19;20.83;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
575;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.172;Q3;19;12;92;282;28;75;0.27;23.5;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Marketing (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q3)"
576;19700201410;Milestones in Drug Therapy;book series;22966056;0.172;Q3;5;13;81;837;20;77;0;64.38;United States;Northern America;Springer Science + Business Media;2010-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Drug Discovery (Q4)"
577;73076;Drug Discovery World;journal;14694344;0.171;Q4;13;29;125;316;34;112;0.35;10.9;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
578;19700175778;International Journal of Research in Pharmaceutical Sciences (discontinued);journal;09757538;0.171;Q3;21;49;224;1037;65;224;0.31;21.16;India;Asiatic Region;"JK Welfare &amp; Pharmascope Foundation";2010-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
579;80593;Journal of Medicinal Plants;journal;16840240;0.171;Q4;23;49;191;1884;58;191;0.16;38.45;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
580;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.17;Q3;32;869;2567;3669;828;2567;0.28;4.22;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
581;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.169;Q4;11;12;109;345;28;109;0.29;28.75;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
582;79053;Natural Product Sciences;journal;12263907;0.169;Q4;28;50;151;1045;52;150;0.3;20.9;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
583;19700174933;Journal of Pharmaceutical Sciences and Research (discontinued);journal;09751459;0.166;Q3;30;293;234;6508;91;234;0.34;22.21;India;Asiatic Region;;2009-2018, 2020-2021;Pharmaceutical Science (Q3)
584;21211;Pharmacy Education;journal;14772701, 15602214;0.166;Q3;18;43;51;945;18;51;0.29;21.98;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Education (Q4)"
585;21100248874;Dilemas;journal;19835922, 21782792;0.165;-;9;42;56;1315;11;54;0.2;31.31;Brazil;Latin America;Universidade Federal do Rio de Janeiro - UFRJ;2013-2021;"Law (Q3); Sociology and Political Science (Q3)"
586;21100301603;National Journal of Physiology, Pharmacy and Pharmacology (discontinued);journal;23204672, 22313206;0.165;Q3;13;94;126;1922;38;115;0.32;20.45;India;Asiatic Region;Mrs Dipika Charan for MedScience Publishers;2011-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Physiology (Q4)"
587;17700155411;Research Journal of Environmental Toxicology (discontinued);journal;18193420;0.165;Q4;18;30;36;1107;18;36;0.38;36.9;United States;Northern America;Academic Journals Inc.;2009-2016;"Pollution (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
588;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;0.164;Q4;14;43;68;1392;39;68;0.72;32.37;Italy;Western Europe;ASLERD;2012-2021;"Architecture (Q2); Media Technology (Q2); Social Sciences (miscellaneous) (Q3); Computer Science Applications (Q4); Human-Computer Interaction (Q4); Pharmacology (Q4)"
589;21100451405;Natural Products Journal;journal;22103163, 22103155;0.164;Q4;13;31;119;1551;56;113;0.51;50.03;Netherlands;Western Europe;Bentham Science Publishers B.V.;2011-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
590;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.163;Q4;17;36;103;706;31;89;0.3;19.61;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2012-2021;"Cardiology and Cardiovascular Medicine (Q3); Critical Care and Intensive Care Medicine (Q3); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
591;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.163;Q3;15;19;89;288;17;78;0.15;15.16;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
592;11200153306;Journal of Pharmacology and Toxicology (discontinued);journal;1816496X, 2152100X;0.163;Q3;18;8;67;308;38;67;0.13;38.5;United States;Northern America;Academic Journals Inc.;2008-2017;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
593;21100804474;European Pharmaceutical Journal;journal;24536725;0.162;Q3;8;30;63;591;20;62;0.33;19.7;Germany;Western Europe;de Gruyter;2016-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
594;110097;Food and Drug Law Journal;journal;1064590X;0.162;Q4;22;29;69;0;21;68;0.28;0;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4)"
595;21100241763;International Journal of Green Nanotechnology;journal;19430906, 19430892;0.162;Q3;4;0;11;0;5;10;0.45;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2014;"Materials Science (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Biomedical Engineering (Q4); Chemistry (miscellaneous) (Q4); Electrical and Electronic Engineering (Q4)"
596;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.16;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
597;19700174926;International Journal of Health Research;journal;15969819, 15969886;0.16;Q4;9;0;5;0;1;5;0;0;Nigeria;Africa;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
598;20400195018;International Journal of Pharmacognosy and Phytochemical Research (discontinued);journal;09754873;0.157;Q4;19;224;287;6106;79;287;0.25;27.26;India;Asiatic Region;International Journal of Pharmacognosy and Phytochemical Research;2011-2016, 2020;Drug Discovery (Q4)
599;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.157;Q3;10;18;63;505;14;63;0.17;28.06;Jordan;Middle East;The University of Jordan;2009-2021;Pharmaceutical Science (Q3)
600;21100237602;Journal of Pharmacy and Nutrition Sciences (discontinued);journal;19275951, 22233806;0.157;Q3;12;18;88;591;27;88;0.2;32.83;Canada;Northern America;;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4)"
601;21100265336;International Arabic Journal of Antimicrobial Agents (discontinued);journal;21749094;0.154;Q4;8;2;46;50;12;46;0;25;Spain;Western Europe;Internet Medical Publishing;2011-2015;"Pharmacology (medical) (Q3); Microbiology (medical) (Q4); Pharmacology (Q4)"
602;19900192735;International Drug Discovery;journal;21504806, 21504792;0.154;Q4;4;0;4;0;1;4;0;0;United States;Northern America;Russell Publishing LLC;2011-2012;Drug Discovery (Q4)
603;19700188484;Journal of Bioequivalence and Bioavailability (discontinued);journal;09750851;0.153;Q3;12;0;120;0;60;88;0.59;0;United States;Northern America;OMICS Publishing Group;2011-2014;Pharmaceutical Science (Q3)
604;19700175040;Open Vaccine Journal;journal;18750354;0.152;Q3;9;0;6;0;3;5;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4)"
605;21823;Pharmacia;journal;04280296;0.152;Q3;16;23;61;779;10;61;0.19;33.87;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacy (Q3)"
606;20564;Ceska a Slovenska Farmacie;journal;12107816;0.151;Q3;17;27;125;555;31;119;0.24;20.56;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
607;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0.151;Q3;7;15;15;297;7;15;0.47;19.8;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011, 2013-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
608;19700182629;Methods in Pharmacology and Toxicology;book series;15572153, 19406053;0.151;Q3;10;61;108;2824;23;101;0.21;46.3;United States;Northern America;Humana Press;2008, 2012, 2014-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
609;25197;Revista de Toxicologia (discontinued);journal;02127113;0.151;Q4;11;30;48;895;15;46;0.24;29.83;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
610;19700188326;American Journal of Drug Discovery and Development (discontinued);journal;2150427X, 21504296;0.15;Q4;12;3;71;126;32;71;0.35;42;United States;Northern America;Academic Journals Inc.;2011-2015;Drug Discovery (Q4)
611;19700175061;Open Pharmacology Journal;journal;18741436;0.149;Q3;6;0;9;0;3;8;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
612;5800179590;Pharmacologyonline (discontinued);journal;18278620;0.149;Q4;27;57;222;1833;60;222;0.27;32.16;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
613;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.148;-;12;30;146;888;21;146;0.16;29.6;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q4)
614;19900191846;PharmacoEconomics - German Research Articles;journal;1868677X, 16123727;0.147;Q3;3;0;8;0;2;7;0;0;New Zealand;Pacific Region;Adis Press;2010-2012;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
615;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.147;Q4;14;28;57;31;14;57;0.27;1.11;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
616;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.146;Q3;18;48;239;1551;60;239;0.25;32.31;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q3)
617;19700175039;Open Toxicology Journal;journal;18743404;0.145;Q4;8;0;8;0;3;7;0.5;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2010, 2012-2013;Toxicology (Q4)
618;73430;Pharmaceutical Technology;journal;15432521;0.145;Q3;38;141;532;618;51;499;0.07;4.38;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q3); Biophysics (Q4)"
619;19700188309;Journal of Bioanalysis and Biomedicine (discontinued);journal;1948593X;0.144;Q3;11;0;66;0;19;44;0.2;0;United States;Northern America;OMICS Publishing Group;2010-2014;Pharmaceutical Science (Q3)
620;19408;Actualites Pharmaceutiques;journal;05153700;0.143;Q4;5;176;578;879;14;486;0.04;4.99;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
621;22934;Chinese Pharmaceutical Journal;journal;10012494;0.143;Q3;21;418;1421;7294;273;1421;0.21;17.45;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
622;4700152607;Current Enzyme Inhibition;journal;15734080;0.143;Q4;18;17;46;570;11;40;0.24;33.53;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
623;21100205709;International Journal of Toxicological and Pharmacological Research (discontinued);journal;09755160;0.142;Q3;10;43;68;1395;18;68;0.27;32.44;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
624;19700201521;Journal of Chemical and Pharmaceutical Research (discontinued);journal;09757384;0.142;Q3;39;180;3541;4758;1115;3540;0.24;26.43;India;Asiatic Region;JOCPR;2004, 2011-2016;Pharmaceutical Science (Q3)
625;19700175149;African Journal Biomedical Research;journal;11195096;0.141;Q3;17;28;84;974;16;84;0.1;34.79;Nigeria;Africa;Ibadan Biomedical Communications Group;2008, 2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Medicine (miscellaneous) (Q4)"
626;19700174924;Biomedical and Pharmacology Journal;journal;09746242;0.14;Q4;22;378;235;8210;52;235;0.28;21.72;India;Asiatic Region;Oriental Scientific Publishing Company;2009-2021;Pharmacology (Q4)
627;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.14;Q4;12;96;345;1265;23;345;0.06;13.18;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
628;22908;Chinese Pharmacological Bulletin;journal;10011978;0.139;Q4;17;366;1234;6711;373;1234;0.34;18.34;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
629;21142;Pharmaceutisch Weekblad;journal;00316911;0.139;Q4;9;444;1207;857;4;902;0;1.93;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
630;21100256959;Biomarkers and Genomic Medicine;journal;22140247;0.138;Q4;12;23;56;818;15;56;0.27;35.57;United States;Northern America;Elsevier BV;2013-2015;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
631;20065;BioPharm International;trade journal;1542166X, 19391862;0.138;Q3;29;140;370;664;48;347;0.11;4.74;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q3); Biotechnology (Q4)"
632;17300154738;Current Trends in Biotechnology and Pharmacy;journal;22307303, 09738916;0.138;Q3;14;34;143;1011;31;143;0.15;29.74;India;Asiatic Region;Association of Biotechnology and Pharmacy;2009-2021;"Pharmaceutical Science (Q3); Biotechnology (Q4); Drug Discovery (Q4)"
633;21100421502;International Journal of Biomedical Nanoscience and Nanotechnology;journal;17560802, 17560799;0.138;Q3;8;0;7;0;3;7;0;0;Switzerland;Western Europe;Inderscience Publishers;2011;"Pharmaceutical Science (Q3); Biomedical Engineering (Q4); Medicine (miscellaneous) (Q4)"
634;19700200861;International Journal of Pharmaceutical Sciences;journal;09754725;0.138;Q3;11;0;66;0;17;66;0;0;India;Asiatic Region;R R College of Pharmacy;2010, 2012-2013;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
635;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.138;Q4;47;271;811;6357;116;811;0.14;23.46;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
636;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.137;Q3;17;16;24;837;10;21;0.46;52.31;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q3); Pharmacology (Q4); Pharmacology (medical) (Q4)"
637;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277, 09644679;0.137;Q3;6;20;68;166;13;56;0.19;8.3;United Kingdom;Western Europe;Pharmaceutical and Healthcare Sciences Society;2010-2016, 2018-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
638;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.137;Q3;9;69;168;1686;18;157;0.11;24.43;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4)"
639;19700174925;European Pharmaceutical Review;trade journal;13608606;0.136;Q4;8;71;167;759;22;163;0.14;10.69;United Kingdom;Western Europe;Russell Publishing LLC;2009-2019;"Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
640;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.136;Q3;11;73;229;0;62;223;0.24;0;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q3); Pharmacy (Q3); Medicine (miscellaneous) (Q4); Pharmacology (medical) (Q4)"
641;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.135;Q4;14;46;110;1086;19;110;0.3;23.61;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
642;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.135;Q4;15;100;351;1111;63;351;0.16;11.11;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
643;19700201140;Systematic Reviews in Pharmacy (discontinued);journal;09758453, 09762779;0.135;Q3;28;4;17;101;4;17;0.3;25.25;India;Asiatic Region;EManuscript Technologies;2010-2021;Pharmaceutical Science (Q3)
644;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0.135;Q4;9;40;89;1162;18;83;0.15;29.05;France;Western Europe;Elsevier Masson s.r.l.;2014-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
645;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.134;Q3;17;645;1836;5442;328;1663;0.16;8.44;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Pharmaceutical Science (Q3); Complementary and Alternative Medicine (Q4); Drug Discovery (Q4); Pharmacology (medical) (Q4)"
646;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.134;Q4;14;25;79;2307;17;74;0.27;92.28;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
647;19700201471;International Journal of Pharmacy and Technology (discontinued);journal;0975766X;0.134;Q4;23;251;335;4553;62;335;0.12;18.14;India;Asiatic Region;International Journal of Pharmacy and Technology(IJPT);2011-2016;"Biomedical Engineering (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
648;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.134;Q4;10;47;132;1141;23;130;0.17;24.28;Netherlands;Western Europe;IOS Press BV;2010-2021;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
649;19700181241;Physiology and Pharmacology;journal;17350581;0.134;Q4;12;44;135;1600;31;133;0.26;36.36;Iran;Middle East;Neuroscience Research Center;2009-2021;"Pharmacology (Q4); Physiology (Q4)"
650;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.133;Q3;14;13;47;352;11;47;0.19;27.08;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Pharmaceutical Science (Q3); Medicine (miscellaneous) (Q4)"
651;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.133;Q4;10;60;329;1295;32;329;0.12;21.58;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
652;17600155051;Drug Development and Delivery;trade journal;1944818X, 15372898;0.133;Q3;11;76;258;296;29;110;0.1;3.89;United States;Northern America;Drug Delivery Technology;2009-2021;Pharmaceutical Science (Q3)
653;21100456601;Journal of Pharmacy and Pharmacognosy Research;journal;07194250;0.133;Q3;10;22;25;503;7;24;0.28;22.86;Chile;Latin America;Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA);2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
654;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.133;Q4;13;49;158;721;14;122;0.1;14.71;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
655;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.132;Q3;9;38;131;188;7;124;0.04;4.95;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;Pharmaceutical Science (Q3)
656;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.132;Q4;6;59;119;224;10;101;0.08;3.8;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q4); Pharmaceutical Science (Q4)"
657;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;0.131;Q4;18;497;637;12155;122;637;0.22;24.46;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
658;21100301409;Issues in Toxicology;book series;17577179, 17577187;0.131;Q4;16;39;166;3732;41;152;0.22;95.69;United Kingdom;Western Europe;Royal Society of Chemistry;2007-2021;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
659;21265;Drugs of the Future;journal;03778282;0.13;Q4;45;106;347;2940;55;341;0.14;27.74;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
660;19700175031;Research Journal of Pharmacology (discontinued);journal;19936019, 18159362;0.129;Q4;9;0;25;0;5;25;0;0;Pakistan;Asiatic Region;Medwell Publishing;2008-2014, 2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
661;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;1943085X, 19430906;0.128;Q4;15;0;63;0;26;63;0;0;United States;Northern America;Taylor and Francis Ltd.;2009-2012;"Biomedical Engineering (Q4); Nanoscience and Nanotechnology (Q4); Pharmaceutical Science (Q4)"
662;21100199794;Industrial Pharmacy;trade journal;17414911;0.127;Q4;4;12;56;64;7;56;0.06;5.33;United Kingdom;Western Europe;Euromed Communications;2011-2016;Pharmaceutical Science (Q4)
663;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.127;Q4;13;42;115;908;22;113;0.18;21.62;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q4)
664;24097;Journal of the Indian Chemical Society;journal;00194522;0.127;Q4;33;305;808;7266;154;804;0.18;23.82;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
665;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.127;Q4;9;20;111;661;8;94;0.06;33.05;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
666;21100291830;Selenium in the Environment and Human Health - Proceedings of the 3rd International Conference on Selenium in the Environment and Human Health;conference and proceedings;-;0.127;-;5;0;92;0;18;90;0.2;0;Netherlands;Western Europe;;;"Health, Toxicology and Mutagenesis; Toxicology"
667;15842;Journal of Applied Research;journal;1537064X;0.126;Q4;22;0;19;0;7;19;0.33;0;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
668;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.126;Q4;5;39;114;697;9;99;0.08;17.87;Czech Republic;Eastern Europe;SOLEN S.R.O.;2009-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
669;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.125;Q4;20;25;93;777;9;90;0.04;31.08;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
670;19700201516;Journal of Chemical and Pharmaceutical Sciences (discontinued);journal;09742115;0.125;Q4;25;527;242;6731;39;242;0.14;12.77;India;Asiatic Region;SPB Pharma Society;2010-2016;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
671;19700200880;Botulinum Journal;journal;17547326, 17547318;0.124;Q4;6;0;14;0;4;13;0.25;0;Switzerland;Western Europe;Inderscience Publishers;2009-2013, 2016;"Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
672;21100196907;Open Toxinology Journal;journal;18754147;0.124;Q4;2;0;1;0;1;1;1;0;Netherlands;Western Europe;;;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (medical) (Q4); Toxicology (Q4)"
673;19700170837;Vitae;journal;21452660, 01214004;0.124;Q4;15;77;180;1084;20;75;0.05;14.08;Colombia;Latin America;Universidad de Antioquia;2009-2021;"Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
674;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.123;Q4;11;13;43;155;3;24;0.08;11.92;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
675;21100818733;Archives of Pharmacy Practice;journal;2045080X;0.123;Q4;2;0;1;0;0;1;0;0;India;Asiatic Region;Wolters Kluwer Medknow Publications;2014, 2016;Pharmaceutical Science (Q4)
676;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.123;Q4;3;16;52;54;2;52;0.03;3.38;Azerbaijan;Eastern Europe;Azerbaijan Medical University;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
677;25253;Blutalkohol (discontinued);journal;00065250;0.123;Q4;13;41;74;228;5;70;0.1;5.56;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
678;21100782803;Current Psychopharmacology;journal;22115560, 22115579;0.123;Q4;4;4;1;248;0;1;0;62;Netherlands;Western Europe;Bentham Science Publishers B.V.;2012, 2015-2016;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
679;22375;Indian Drugs;journal;0019462X;0.123;Q4;31;81;241;1644;27;241;0.08;20.3;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
680;21100785532;International Journal of Pharma Medicine and Biological Sciences;journal;22785221;0.123;Q4;1;0;1;0;0;1;0;0;India;Asiatic Region;;2012, 2016;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
681;21100205919;Open Drug Discovery Journal;journal;18773818;0.123;Q4;9;0;1;0;0;1;0;0;United Arab Emirates;Middle East;Bentham open;2010, 2014;Drug Discovery (Q4)
682;21100784233;Proceedings of the 2013 21st Euromicro International Conference on Parallel, Distributed, and Network-Based Processing, PDP 2013;conference and proceedings;-;0.123;-;0;0;1;0;0;1;0;0;United States;Northern America;;;"Pharmaceutical Science; Statistics and Probability"
683;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;0.123;Q4;3;0;1;0;0;1;0;0;Russian Federation;Eastern Europe;JSC;2009-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
684;19700174987;Research Journal of Toxins (discontinued);journal;18193560, 21517258;0.123;Q4;3;0;1;0;1;1;1;0;United States;Northern America;Academic Journals Inc.;2009, 2014, 2016;"Agronomy and Crop Science (Q4); Food Science (Q4); Toxicology (Q4)"
685;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;20660170, 15830012;0.123;Q4;3;24;69;524;4;68;0.03;21.83;Romania;Eastern Europe;Rp Publishing House;2011-2012, 2014-2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
686;19700175137;Trends in Medical Research (discontinued);journal;18193587, 21516065;0.123;Q4;10;13;21;392;9;21;0.27;30.15;United States;Northern America;Academic Journals Inc.;2008-2016, 2020-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
687;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.121;Q4;16;120;271;1999;26;271;0.07;16.66;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
688;22906;Journal of China Pharmaceutical University;journal;10005048;0.12;Q4;14;121;323;2926;58;323;0.19;24.18;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
689;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.119;Q4;12;183;442;4317;78;441;0.19;23.59;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
690;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.119;Q4;19;267;726;1997;17;705;0.03;7.48;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q4)
691;19900192173;International Journal of Pharmaceutical and Clinical Research (discontinued);journal;09751556;0.118;Q4;13;92;109;2531;22;109;0.2;27.51;Australia;Pacific Region;International Journal of Pharmaceutical and Clinical Research;2011-2016;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
692;19700201509;Pharma Research (discontinued);journal;09758216;0.118;Q4;5;9;71;356;7;71;0.09;39.56;India;Asiatic Region;Sudarshan Publications;2011-2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
693;21100195303;Eurasian Journal of Analytical Chemistry (discontinued);journal;13063057;0.117;Q4;16;15;38;357;12;38;0.25;23.8;Turkey;Middle East;Moment Publications;2010-2018, 2020;"Analytical Chemistry (Q4); Electrochemistry (Q4); Pharmaceutical Science (Q4); Spectroscopy (Q4)"
694;5200152604;Pharma Times;journal;00316849;0.117;Q4;12;88;259;666;16;140;0.09;7.57;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
695;19700174940;SA Pharmaceutical Journal;journal;10151362;0.116;Q4;7;96;323;795;24;223;0.06;8.28;South Africa;Africa;Medpharm Publications;2009-2021;Pharmaceutical Science (Q4)
696;21100788832;International Journal of Medicinal Chemistry;journal;20902069, 20902077;0.115;Q4;4;1;2;22;1;2;0.5;22;United States;Northern America;Hindawi Publishing Corporation;2014-2016;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
697;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685, 19054637;0.115;Q4;12;23;194;587;22;192;0.18;25.52;Thailand;Asiatic Region;Thai Journal of Pharmaceutical Sciences;2009-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
698;21798;Farmaceutski Glasnik;journal;00148202;0.114;Q4;6;63;226;341;5;186;0.02;5.41;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
699;19900194805;Genomic Medicine, Biomarkers, and Health Sciences;journal;22114254, 22114262;0.114;Q4;7;0;34;0;6;34;0;0;Taiwan;Asiatic Region;Elsevier Taiwan LLC;2011-2012;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
700;19700174658;Regulatory Rapporteur;trade journal;17428955;0.114;Q4;6;60;229;391;16;172;0.07;6.52;United Kingdom;Western Europe;TOPRA;2010-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Pharmacy (Q4)"
701;21000195625;Asian Journal of Pharmaceutical Research and Health Care (discontinued);journal;22501444, 22501460;0.113;Q4;6;2;41;44;6;37;0.16;22;India;Asiatic Region;;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
702;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.113;Q4;9;17;10;680;1;10;0;40;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
703;19700194018;Russian Journal of Biopharmaceuticals (discontinued);journal;20738099;0.113;Q4;6;47;109;463;17;108;0.09;9.85;Russian Federation;Eastern Europe;Folium Publishing Company;2011-2021;"Bioengineering (Q4); Drug Discovery (Q4)"
704;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.112;Q4;43;187;417;3987;76;353;0.19;21.32;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
705;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.111;Q4;3;0;3;0;0;2;0;0;France;Western Europe;Elsevier Masson s.r.l.;2005-2012;Pharmaceutical Science (Q4)
706;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.111;Q4;10;41;98;1563;5;84;0.06;38.12;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
707;21100853016;Antibodies;journal;20734468;0.111;Q4;15;22;18;2044;27;17;0;92.91;Switzerland;Western Europe;MDPI AG;2017-2021;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4)"
708;19700174922;Chinese Journal of New Drugs;journal;10033734;0.111;Q4;12;549;1770;6642;145;1770;0.07;12.1;China;Asiatic Region;Chinese Journal of New Drugs Co. Ltd.;2008-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
709;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.111;Q4;18;4;45;117;2;45;0.05;29.25;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
710;21100853528;International Journal of Advances in Pharmaceutical Research;journal;22497226;0.111;Q4;0;4;2;77;0;2;0;19.25;India;Asiatic Region;;;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
711;21100790356;International Journal of Life Sciences Biotechnology and Pharma Research;journal;22503137;0.111;Q4;1;0;2;0;0;2;0;0;India;Asiatic Region;;2012, 2014, 2016;"Applied Microbiology and Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
712;21100785531;International Journal of Medicinal and Aromatic Plants;journal;22494340;0.111;Q4;3;0;2;0;0;2;0;0;India;Asiatic Region;;;"Drug Discovery (Q4); Plant Science (Q4)"
713;19700201404;Open Drug Safety Journal;journal;18768180;0.111;Q4;3;0;2;0;0;2;0;0;Netherlands;Western Europe;;;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
714;21100398550;Orphan Drugs: Research and Reviews;journal;22306161;0.111;Q4;3;10;2;924;0;2;0;92.4;New Zealand;Pacific Region;Dove Medical Press Ltd.;2014-2015, 2017;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
715;19700174966;Pharmakeftiki;journal;22413081, 11054999;0.111;Q4;5;8;39;509;1;34;0;63.63;Greece;Western Europe;Zita Medical Managent;2008-2010, 2012-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
716;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.11;Q4;19;115;356;2113;20;293;0.05;18.37;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
717;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.11;Q4;13;0;87;0;15;86;0.17;0;Iran;Middle East;Iranian Association of Pharmaceutical Scientists;2010-2014, 2016-2021;"Bioengineering (Q4); Pharmaceutical Science (Q4)"
718;22977;Journal de Pharmacie de Belgique;journal;00472166;0.11;Q4;12;27;84;0;20;76;0.33;0;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
719;22358;U.S. Pharmacist;trade journal;01484818;0.11;Q4;9;182;459;3027;31;375;0.07;16.63;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
720;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.109;Q4;7;7;17;237;1;17;0.09;33.86;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
721;19700175108;Drug Delivery System;journal;18812732, 09135006;0.109;Q4;8;53;114;622;2;87;0;11.74;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
722;19700174645;International Journal of Pharmaceutical Research (discontinued);journal;09752366;0.109;Q4;24;49;209;1347;15;207;0.11;27.49;India;Asiatic Region;Advanced Scientific Research;2010-2021;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
723;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.109;Q4;21;3;33;82;5;33;0.04;27.33;Iran;Middle East;Academy of Medical Sciences of I.R. Iran;2006-2015;Pharmacology (Q4)
724;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;0.109;Q4;5;0;3;0;2;3;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2012;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
725;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.109;Q4;10;22;54;263;8;48;0.03;11.95;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
726;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.108;Q4;8;0;32;0;5;32;0.05;0;Egypt;Africa/Middle East;Faculty of Pharmacy, Assiut University;2008-2014, 2018-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
727;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.107;Q4;3;0;43;0;0;40;0;0;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
728;19700200708;Journal of Global Pharma Technology (discontinued);journal;09758542;0.107;Q4;17;2;52;31;4;52;0.06;15.5;India;Asiatic Region;Journal of Global Pharma Technology;2010-2020;Pharmaceutical Science (Q4)
729;22887;Chinese Journal of Antibiotics;journal;10018689;0.106;Q4;11;93;544;1596;27;544;0.02;17.16;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
730;19700174992;European Journal of Oncology Pharmacy;journal;17833914;0.106;Q4;4;21;75;18;2;60;0.03;0.86;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2015, 2017-2019;"Oncology (Q4); Pharmacology (Q4)"
731;21100202747;GMP Review;trade journal;14764547;0.106;Q4;2;5;45;46;4;44;0.09;9.2;United Kingdom;Western Europe;Euromed Communications Ltd;2011-2015, 2017-2021;Pharmaceutical Science (Q4)
732;21100853529;International Journal of Pharmaceutical and Phytopharmacological Research;journal;22501029;0.106;Q4;2;3;4;147;0;4;0;49;India;Asiatic Region;;;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
733;19700175049;Internet Journal of Toxicology;journal;15593916;0.106;Q4;7;1;6;13;2;6;0.33;13;United States;Northern America;Internet Scientific Publications, LLC;2009-2011, 2013, 2015;Toxicology (Q4)
734;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.106;Q4;7;215;726;2776;50;726;0.08;12.91;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
735;19700175071;Open Bioactive Compounds Journal;journal;18748473;0.106;Q4;6;0;4;0;1;4;0.25;0;Netherlands;Western Europe;;;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
736;21102;Pharmaceutical Journal;journal;00316873;0.106;Q4;28;393;1129;859;19;466;0.01;2.19;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
737;22514;Japanese Journal of Chemotherapy;journal;13407007;0.105;Q4;12;20;64;220;7;64;0.15;11;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
738;22979;Journal of Applied Therapeutic Research;journal;10292659;0.105;Q4;8;0;5;0;0;5;0;0;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
739;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.104;Q4;11;0;6;0;0;6;0;0;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
740;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.104;Q4;5;137;224;3625;8;219;0.04;26.46;China;Asiatic Region;Editorial office of Chinese Journal of Cancer Biotherapy;2008-2011, 2013-2016, 2018-2022;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
741;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.104;Q4;5;46;165;328;6;158;0.05;7.13;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
742;5200152843;Farmaceutico Hospitales;journal;02144697;0.104;Q4;3;0;10;0;0;6;0;0;Spain;Western Europe;Ediciones Mayo S.A.;2006-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
743;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.104;Q4;12;0;44;0;5;44;0.1;0;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
744;19700174997;ONdrugDelivery;trade journal;2049145X, 20491468;0.104;Q4;6;70;147;332;12;93;0.08;4.74;United Kingdom;Western Europe;Frederick Furness Publishing;2009-2020;Pharmaceutical Science (Q4)
745;19700177006;Psychopharm Review;trade journal;19369255;0.104;Q4;4;0;26;0;3;26;0.14;0;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2009-2014;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
746;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.103;Q4;8;7;22;122;4;20;0;17.43;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
747;9100153105;Current Topics in Pharmacology;journal;09724559;0.103;Q4;6;10;38;397;1;38;0.04;39.7;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
748;13000154717;Current Topics in Toxicology;journal;09728228;0.103;Q4;7;9;20;258;3;20;0.25;28.67;India;Asiatic Region;Research Trends;2007-2009, 2011-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
749;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.103;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
750;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.103;Q4;6;16;45;579;3;44;0.07;36.19;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
751;13637;Manufacturing Chemist;trade journal;02624230;0.102;Q4;6;16;364;51;1;324;0;3.19;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
752;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.102;Q4;7;5;9;85;0;9;0;17;India;Asiatic Region;Medicinal and Aromatic Plants Association of India;2010-2019;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
753;20543;Pharmacometrics;journal;03008533;0.102;Q4;6;0;14;0;0;14;0;0;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
754;21243;Pharmacy Times;trade journal;00030627;0.102;Q4;8;296;908;1299;18;340;0.02;4.39;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
755;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.102;Q4;13;0;74;0;5;66;0;0;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
756;21100456702;3rd International Conference on Accelerating Biopharmaceutical Development 2013;conference and proceedings;-;0.101;-;1;0;17;0;0;16;0;0;United States;Northern America;;;Safety, Risk, Reliability and Quality
757;19700174886;Arzneimitteltherapie;journal;07236913;0.101;Q4;6;198;488;1230;7;243;0.01;6.21;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;2008-2021;"Pharmacology (medical) (Q4); Pharmacology (nursing) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
758;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.101;Q4;5;128;401;1560;11;401;0.03;12.19;China;Asiatic Region;China Pharmaceutical University;2007-2021;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
759;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.101;Q4;2;0;67;0;0;31;0;0;Germany;Western Europe;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
760;21100829925;HiSTOReLo;journal;2145132X;0.101;-;3;22;46;882;2;37;0.04;40.09;Colombia;Latin America;Universidad Nacional de Colombia;2013-2021;History (Q4)
761;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.101;Q4;5;11;26;164;0;26;0;14.91;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
762;21127;Pharmaceutical Technology Europe;journal;01646826;0.101;Q4;18;146;284;747;4;221;0.02;5.12;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q4)
763;19700175580;PharmacoVigilance Review;journal;17526752;0.101;Q4;2;18;34;60;1;25;0.07;3.33;United Kingdom;Western Europe;Euromed Communications;2010-2019;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
764;20572;PZ Prisma;journal;09455566;0.101;Q4;5;38;105;605;1;93;0;15.92;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
765;21100201517;RSC Drug Discovery Series;book series;20413203, 20413211;0.101;Q4;10;121;18;12001;0;16;0;99.18;United Kingdom;Western Europe;Royal Society of Chemistry;2010, 2014-2021;Drug Discovery (Q4)
766;5800207507;Side Effects of Drugs Annual;book series;03786080;0.101;Q4;6;49;161;3827;5;4;0.02;78.1;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
767;21100208082;VacciMonitor;journal;10250298, 1025028X;0.101;Q4;5;3;65;61;6;61;0.07;20.33;Cuba;Latin America;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-2021;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Molecular Medicine (Q4)"
768;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.1;Q4;6;0;70;0;0;70;0;0;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
769;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;3;27;91;372;0;79;0;13.78;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
770;19700173109;Contract Pharma;trade journal;15443469, 23806559;0.1;Q4;4;112;428;174;4;396;0.01;1.55;United States;Northern America;Contract Pharma;2009-2018;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
771;21238;Drug Topics;journal;19378157, 00126616;0.1;Q4;8;287;742;79;3;75;0.01;0.28;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
772;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.1;Q4;3;19;176;75;0;162;0;3.95;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
773;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.1;Q4;5;35;80;734;7;77;0.14;20.97;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
774;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.1;Q4;7;13;80;279;1;70;0.02;21.46;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q4)
775;21100435458;Food, Pharmaceutical and Bioengineering Division 2015 - Core Programming Area at the 2015 AIChE Meeting;conference and proceedings;-;0.1;-;1;65;190;320;1;188;0.01;4.92;United States;Northern America;;;"Computer Networks and Communications; Computer Science Applications"
776;21867;Geneesmiddelenbulletin;journal;03044629;0.1;Q4;7;56;172;951;0;112;0;16.98;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
777;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.1;Q4;7;33;236;327;4;223;0.02;9.91;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
778;21100348334;Pharmaceutical Discovery, Development and Manufacturing Forum 2013 - Core Programming Area at the 2013 AIChE Annual Meeting: Global Challenges for Engineering a Sustainable Future;conference and proceedings;-;0.1;-;1;0;74;0;0;72;0;0;United States;Northern America;;;"Organic Chemistry; Pharmaceutical Science"
779;21100446069;Pharmaceutical Discovery, Development and Manufacturing Forum 2014 - Core Programming Area at the 2014 AIChE Annual Meeting;conference and proceedings;-;0.1;-;1;0;53;0;0;52;0;0;United States;Northern America;;;Engineering (miscellaneous)
780;19700174975;Pharmaceutical Formulation and Quality;trade journal;15312135, 19363435;0.1;Q4;1;0;47;0;0;47;0;0;United States;Northern America;Wiley-Blackwell;2010-2012;Pharmaceutical Science (Q4)
781;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.1;Q4;3;50;179;136;0;176;0;2.72;United Kingdom;Western Europe;Samedan Ltd;2009-2016, 2018-2019;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
782;19700175034;Pharmaceutical Processing;trade journal;10499156;0.1;Q4;3;39;202;18;1;60;0;0.46;United States;Northern America;Advantage Business Media;2009-2018;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
783;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;0.1;Q4;2;8;728;16;0;643;0;2;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
784;21716;Pharmazeutische Zeitung;journal;00317136;0.1;Q4;7;790;2013;536;1;1161;0;0.68;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
785;21100446017;Proceedings of the 16th International Association for Mathematical Geosciences - Geostatistical and Geospatial Approaches for the Characterization of Natural Resources in the Environment: Challenges, Processes and Strategies, IAMG 2014;conference and proceedings;-;0.1;-;2;0;148;0;0;146;0;0;India;Asiatic Region;;;"Organic Chemistry; Pharmaceutical Science"
786;16800154712;Sp2;trade journal;1476184X;0.1;Q4;2;0;109;0;0;92;0;0;United Kingdom;Western Europe;Avakado Ltd;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
787;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.1;Q4;10;0;104;0;0;101;0;0;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q4)
788;21100841779;ADMET and DMPK;journal;18487718;;-;15;31;33;1789;35;29;1.06;57.71;Croatia;Eastern Europe;International Association of Physical Chemists;2013-2021;"Chemistry (miscellaneous); Health (social science); Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
789;21100854233;Advances in Delivery Science and Technology;book series;21926204;;-;2;5;0;875;0;0;0;175;Germany;Western Europe;Springer Verlag;2015;Pharmaceutical Science
790;21100853960;Anti-Tumor Pharmacy;journal;20951264;;-;2;9;11;290;0;11;0;32.22;China;Asiatic Region;;2014-2016;"Oncology; Pharmaceutical Science; Pharmacology (medical)"
791;21100854647;Applied In Vitro Toxicology;journal;23321512, 23321539;;-;12;1;0;46;0;0;0;46;United States;Northern America;Mary Ann Liebert Inc.;2015-2021;"Health, Toxicology and Mutagenesis; Medical Laboratory Technology; Toxicology"
792;21100986051;Cancer Drug Discovery and Development;book series;21969906, 21969914;;-;5;47;18;5099;4;17;0.22;108.49;United States;Northern America;Springer New York;2014-2015, 2017-2020;"Cancer Research; Drug Discovery; Oncology"
793;21100853500;Clinical Cancer Drugs;journal;22126988, 2212697X;;-;4;5;0;395;0;0;0;79;United Arab Emirates;Middle East;Bentham Science Publishers;2015-2016;"Cancer Research; Oncology; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
794;21100446418;Contemporary Clinical Trials Communications;journal;24518654;;-;17;9;0;136;0;0;0;15.11;United States;Northern America;Elsevier Inc.;2015-2021;"Medicine (miscellaneous); Pharmacology"
795;21100873055;Cosmetics;journal;20799284;;-;27;33;20;1373;14;19;0.7;41.61;Switzerland;Western Europe;MDPI AG;2014-2021;"Aging; Chemical Engineering (miscellaneous); Dermatology; Pharmaceutical Science; Surgery"
796;21100853871;Current Metabolomics;journal;22132368, 2213235X;;-;4;3;0;199;0;0;0;66.33;Netherlands;Western Europe;Bentham Science Publishers B.V.;2015-2016;"Analytical Chemistry; Biochemistry, Genetics and Molecular Biology (miscellaneous); Biochemistry (medical); Drug Discovery; Organic Chemistry"
797;21100793213;Current Pharmacology Reports;journal;2198641X;;-;26;42;0;3997;0;0;0;95.17;Switzerland;Western Europe;Springer International Publishing AG;2015-2021;"Biochemistry; Drug Discovery; Genetics; Pharmacology"
798;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;38;130;3017;217;123;1.68;79.39;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
799;21100854828;Current Traditional Medicine;journal;22150846, 22150838;;-;4;1;0;51;0;0;0;51;Netherlands;Western Europe;Bentham Science Publishers B.V.;2015-2017, 2020-2021;"Complementary and Alternative Medicine; Drug Discovery"
800;21100819608;Emerging Contaminants;journal;24056650, 24056642;;-;24;8;0;431;0;0;0;53.88;China;Asiatic Region;KeAi Communications Co.;2015-2021;"Health, Toxicology and Mutagenesis; Public Health, Environmental and Occupational Health; Toxicology"
801;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;24;101;715;71;100;0.71;29.79;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
802;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;;-;7;10;33;644;6;33;0;64.4;Turkey;Middle East;Hacettepe University, Faculty of Pharmacy;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
803;21100853531;Indian Journal of Novel Drug Delivery;journal;09755500;;-;0;1;0;30;0;0;0;30;India;Asiatic Region;Karnataka Education and Scientific Society;2015-2016;Pharmaceutical Science
804;21100853873;International Journal of Current Pharmaceutical Research;journal;09757066;;-;5;6;1;246;0;1;0;41;India;Asiatic Region;Innovare Academic Sciences Pvt Ltd.;2014-2016;Pharmaceutical Science
805;21100820896;Journal of Advanced Pharmacy Education and Research;journal;22493379;;-;8;1;0;23;0;0;0;23;India;Asiatic Region;"Society of Pharmaceutical Education &amp; Research [SPER]";2015, 2017-2021;"Education; Pharmaceutical Science; Pharmacy"
806;21100902935;Journal of Biologically Active Products from Nature;journal;22311874, 22311866;;-;13;41;124;1408;54;124;0.48;34.34;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Agricultural and Biological Sciences (miscellaneous); Complementary and Alternative Medicine; Drug Discovery; Pharmacology; Plant Science; Toxicology"
807;21101022494;Journal of Cardiovascular Development and Disease;journal;23083425;;-;21;18;19;1022;11;17;0.58;56.78;Switzerland;Western Europe;MDPI AG;2014-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
808;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;24;86;405;1;86;0;16.88;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
809;21100853545;Journal of Global Trends in Pharmaceutical Sciences;journal;22307346;;-;1;5;0;168;0;0;0;33.6;India;Asiatic Region;Annamacharya College of Pharmacy;2015-2016;"Molecular Medicine; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
810;21100833039;Journal of HerbMed Pharmacology;journal;23455004;;-;13;31;0;767;0;0;0;24.74;Iran;Middle East;Nickan Research Institute;2015-2021;Drug Discovery
811;21100881509;Journal of International Pharmaceutical Research;journal;16740440;;-;7;119;246;2907;22;246;0.09;24.43;China;Asiatic Region;Editorial office of Journal of International Pharmaceutical Research;2010-2011, 2013-2020;Pharmaceutical Science
812;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;;-;6;6;0;122;0;0;0;20.33;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology
813;21100928216;Journal of Research in Pharmacy;journal;26306344;;-;16;37;80;1286;40;80;0.4;34.76;Turkey;Middle East;Marmara University;2019-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
814;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;293;765;6696;255;757;0.34;22.85;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
815;21100924771;Natural Products and Bioprospecting;journal;21922209, 21922195;;-;26;33;130;1053;193;130;1.27;31.91;Singapore;Asiatic Region;Springer Singapore;2011-2021;"Analytical Chemistry; Biochemistry; Food Science; Organic Chemistry; Pharmacology; Plant Science; Toxicology"
816;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;10;2;0;0;2;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
817;21100875801;npj Systems Biology and Applications;journal;20567189;;-;25;9;0;423;0;0;0;47;United Kingdom;Western Europe;Nature Publishing Group;2015-2021;"Applied Mathematics; Biochemistry, Genetics and Molecular Biology (miscellaneous); Computer Science Applications; Drug Discovery; Modeling and Simulation"
818;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;43;60;1797;118;56;2.15;41.79;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
819;21100977423;RSC Medicinal Chemistry;journal;26328682;;-;62;242;655;9865;1646;637;2.49;40.76;United Kingdom;Western Europe;Royal Society of Chemistry;2020-2021;"Biochemistry; Drug Discovery; Molecular Medicine; Organic Chemistry; Pharmaceutical Science; Pharmacology"
820;21100444313;Sustainable Chemistry and Pharmacy;journal;23525541;;-;27;10;0;576;0;0;0;57.6;Netherlands;Western Europe;Elsevier BV;2015-2021;"Environmental Chemistry; Management, Monitoring, Policy and Law; Pharmaceutical Science; Pollution"
821;21100787110;Therapeutic Advances in Psychopharmacology;journal;20451261, 20451253;;-;26;46;116;1603;221;76;2.01;34.85;United States;Northern America;SAGE Publications Inc.;2011-2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Psychology (miscellaneous)"
822;21100830708;Toxics;journal;23056304;;-;32;26;34;2421;42;33;1.24;93.12;Switzerland;Western Europe;MDPI AG;2013-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
